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STELLINGEN 
1 De conclusie van Ferrante et al., dat een alkylhydroperoxide reductase 
betrokken is bij tolerantie voor oplosmiddelen in een Escherichia coli mutant, 
is onjuist gezien de waarneming van deze auteurs dat deze mutant tolerant is 
voor cyclohexaan. 
Ferrante, A. A., J. Augliera, K. Lewis, and A. M. Klibanov. 1995. Cloning of an organic 
solvent-resistance gene in Escherichia coli: the unexpected role of alkylhydroperoxide 
reductase. Proc. Natl. Acad. Sci. USA 92:7617-7621. 
2 Het foutief gebruik van het woord 'resistentie', om de tolerantie van een 
organisme voor een chemische verbinding weer te geven, wordt door velen 
getolereerd. 
Dit proefschrift 
3 Voor een evenwichtige regionale ontwikkeling zijn gemeenten te klein en 
provincies te groot. 
4 De conclusie van Kobayashi ef al. dat met tolueen gevulde 'membrane 
vesicles' een significante bijdrage leveren aan tolueentolerantie in 
Pseudomonas putida IH-2000, wordt overschat. 
Kobayashi, H., K. Uematsu, H. Hirayama, and K. Horikoshi. 2000. Novel toluene 
elimination system in a toluene-tolerant microorganism. J Bacteriol. 182:6451-6455. 
5 Bij het streven naar 'lichtgewicht' in de buitensport is alles wat men thuis 
laat meegenomen. 
6 Efflux pompen van het 'RND' type hebben een verrassende substraat 
specificiteit. 
Dit proefschrift 
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GENERAL INTRODUCTION 
Pseudomonas putida is a Gram-negative, polarly flagellated, nonspore-forming rod, 
belonging to the family Pseudomonadacea. P. putida grows aerobically with an 
optimal growth temperature of 25-30°C and generally metabolize sugars via the 
Entner-Doudoroff pathway. Anaerobically P. putida is able to obtain its energy via 
nitrate respiration or denitrification but not by fermentation [105]. 
The metabolic and physiological properties of P. putida have been well 
characterized since its isolation in 1889 by Trevisan [139]. P. putida is able to use a 
wide spectrum of substrates and it can even metabolize a large number of 
heterocyclic and aromatic compounds that are not attacked by other bacteria. Due 
to their simple requirements, P. putida is ubiquitous. They are present in soil, 
water, wastewater and air [105]. 
The subject of this thesis is P. putida strain S12. This organism was isolated in 
1990 on the basis of its ability to use styrene as sole carbon and energy source 
[33]. In 1993 it was observed that P. putida S12 was able to grow in the presence of 
high concentrations of styrene and other organic solvents [145]. Since 1993 this 
solvent-tolerant bacterium has been the object of several studies on the 
mechanisms of organic solvent tolerance. It has been observed that cis into trans 
isomerization of the unsaturated membrane phospholipids occur in solvent-tolerant 
cells [34, 146]. Moreover, at the level of the outer membrane changes have been 
found that could play a role in the solvent-tolerant properties of P. putida S12 
[144]. In 1996 strong indications were obtained that toluene was actively 
transported from the membrane of P. putida S12 [55]. Interestingly, solvent-
adapted P. putida S12 cells are more resistant to several antibiotics [58]. These 
putative export systems for solvents and for antibiotics were subsequently studied 
at the molecular level. 
CHAPTER 1 
OUTLINE OF THIS THESIS 
The objective of this Ph.D. study was to identify and to characterize the genes of 
Pseudomonas putida S12 involved in tolerance towards organic solvents and 
antibiotics. 
In Chapter 2 a short overview is given on organic solvent stress response and 
solvent tolerance mechanisms in Gram-negative bacteria. Chapter 2 has been 
published in the ASM book "Bacterial Stress Responses" [62]. 
In Chapter 3 the isolation and sequencing of the first organic solvent transporter is 
described. Furthermore, a comparison is made between the organic solvent 
transporter from P. putida S12 and transporter proteins from bacteria. The role of 
proton-dependent efflux of organic solvents from the bacterial membrane in 
relation to solvent tolerance is discussed. Chapter 3 has been published in "The 
Journal of Biological Chemistry" [64]. 
In Chapter 4 the characterization of the organic solvent transporter of P. putida S12 
is extended by the analysis of the solvent transporter promoter. With the 
construction of a reporter plasmid we were able to identify the compounds 
responsible for the induction of solvent transport. Chapter 4 has been published in 
"The Journal of Bacteriology" [63]. 
In Chapter 5 the isolation and sequencing of a proton-dependent multidrug 
transporter of P. putida S12 is described. A comparison with multidrug transporters 
and organic solvent transporters is made. The role of organic solvent transporters 
in the active efflux of antibiotics is discussed. Chapter 5 has been published in 
"Microbiology" [61]. 
In Chapter 6 we describe the isolation of octanol-sensitive mutants of P. putida S12 
and the partial characterization of the genes interrupted in these mutants. In this 
Chapter we discuss the role of flagellar genes in P. putida S12 solvent tolerance. 
Chapter 6 has been published in "FEMS Microbiology Letters" [65]. 
In Chapter 7 the results presented in this thesis are discussed in general terms. 
Attention is given to future investigations in solvent tolerance mechanisms and to 
the application of these bacteria in biotechnological production processes. 
MECHANISMS OF ORGANIC SOLVENT TOLERANCE IN BACTERIA 
Jasper Kieboom and Jan A.M. de Bont 
SUMMARY 
The extreme toxicity of many organic solvents imposes a severe problem in the 
application of these chemical compounds in biotechnological production processes. 
The main reason for the toxicity of organic solvents is the accumulation of these 
molecules in the bacterial cell membrane, causing adverse effects on membrane 
structure and functioning. However, in the past decade several organic solvent-
tolerant bacteria have been isolated from the environment that are able to survive 
in water-solvent two-phase systems. In these systems the concentrations of organic 
solvents reach levels that are lethal for normal bacteria. Solvent-tolerant bacteria 
are able to counterbalance the detrimental effects of organic solvents via several 
mechanisms that change the structure of the cell envelope. It has now been 
established that active efflux of solvent from the membrane plays a key role in 
organic solvent tolerance. We here review the current knowledge on these 
exceptional bacteria and the mechanisms for their survival in the presence of toxic 
solvents. 
PUBLISHED IN THE ASM BOOK 'BACTERIAL STRESS RESPONSES' ( 2 0 0 0 ) P. 3 9 3 - 4 0 2 
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INTRODUCTION 
Organic solvents are generally regarded as extremely toxic to living microorganisms 
and therefore impose an important drawback in the application of these chemical 
compounds in biotechnology [125]. However, in the past decade efforts have been 
made to isolate microorganisms tolerant to organic solvents. These organisms have 
potential advantages in either the remediation of highly polluted waste-streams or 
biocatalytic applications for the production of specialty chemicals. The use of solvent-
tolerant bacteria in biocatalysis would allow the introduction of an organic phase to 
dissolve water-insoluble substrates or to remove toxic product [17]. 
Toxicity of Organic Solvents 
Because of their toxicity, organic solvents have been widely used as disinfectants, 
permeabilization agents, and food preservatives [16, 90]. The antimicrobial 
property of organic solvents correlates with its hydrophobic nature. The 
hydrophobicity of organic solvents is usually expressed in terms of Pow, which gives 
the partitioning of a compound over an octanol/water two-phase system. It has 
been established that the common logarithm of Pow is inversely correlated with the 
toxicity of the organic solvent [131]. This influence of the log Pow on toxicity toward 
microorganisms has been described for different classes of organic solvents such 
as aromatic compounds, alkanes, alcohols, and phenols [72]. Organic solvents with 
a log P0w value between 1 and 5 are generally regarded as highly toxic for 
microorganisms [103, 130]. It is generally accepted that the accumulation of 
organic solvents in the membrane is the main mechanism for toxicity, although 
other mechanisms cannot be ruled out because of specific chemical properties of 
each specific compound. The mechanism of membrane toxicity of organic solvents 
has been reviewed extensively by Sikkema etal. in 1995. To understand the organic 
solvent tolerance mechanisms of solvent-tolerant bacteria a short overview of 
organic solvent toxicity is given below. 
In most cases, organic solvents, such as aromatic compounds and alcohols, target 
the bacterial cell membrane in which they preferentially partition [103, 130]. De 
Smet etal. first made this visible in 1978 by means of electron microscopic images 
of toluene-treated Escherichia coli cells [132]. While the outer membrane in these 
cells remained intact, considerable damage was done to the cytoplasmic 
membrane, resulting in the permeabilization of the cell membrane. This 
partitioning of organic solvents prevents the proper functioning of the membrane, 
which is a selective barrier for solutes between the cell and its external 
environment. The permeabilization of this barrier impaired the growth of E. coli in 
the presence of toluene and resulted in the leakage of macromolecules such as 
RNA, phospholipids, and proteins [59, 155]. The functioning of the membrane as a 
selective barrier is especially important for protons and some other ions. In a study 
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by Heipieper etal. in 1991, phenol-treated £ co//'cells released ATP and potassium 
ions into medium [38]. The loss of ion gradients over the membrane prevents 
energy transduction in solvent-treated cells. Several other researchers 
demonstrated that the passive flux of ions destroys the gradients over the 
membrane, such as the ApH and the electrical potential Ay, which dissipates the 
electron motive force [13, 130]. 
The accumulation of organic solvents in the membrane of bacteria affects the 
physicochemical properties of the lipid bilayer by changing lipid ordering and 
bilayer stability [144]. An important aspect of the membrane is its fluidity, which is 
defined as the reciprocal of the viscosity. Sikkema et al. showed in 1994 that the 
fluidity increased due to the partitioning of organic solvents in biological 
membranes. This increased fluidity was the result of hydrophobic interactions of 
hydrocarbons within the membrane [130, 131]. In parallel to this, the accumulation 
of hydrocarbons resulted in the swelling of the membrane bilayer. As a result of 
these interactions of solvents with the membrane, its structure and stability were 
affected [129, 131], resulting in a decreased function of membrane-embedded 
proteins. This was demonstrated for a variety of organic solvents by measuring 
cytochrome c oxidase activity in artificial membranes [130]. In E. coli cells it was 
observed that partitioning of toluene resulted in the total inactivation of the 
galactose permease system [59]. 
In conclusion, the accumulation of organic solvents results in the disruption of the 
membrane structure and bilayer stability by increasing membrane fluidity. These 
adverse effects on the membrane will cause the loss of membrane functions, 
leading to cell death. 
SOLVENT-TOLERANT BACTERIA 
Despite the extreme toxicity of organic solvents, Inoue and Horikoshi in 1989 were 
able to isolate the first solvent-tolerant Pseudomonas putida strain that was able to 
grow in a two-phase water-toluene system [49]. This discovery was confirmed for 
several other P. putida strains [15, 116, 145] and also for other representatives of 
the genus Pseudomonas [47, 97, 99]. Furthermore, solvent tolerance has been 
found in other Gram-negative genera such as Flavobacterium [88] and Alcaligenes 
[99]. Solvent tolerance was also determined in Gram-positive genera such as 
Rhodococcus [104] and Bacillus [57, 87]. In addition to the naturally solvent-
tolerant strains, several researchers were able to isolate solvent-tolerant mutants 
with enhanced resistance properties from non-tolerant strains. In this way, mutants 
of £ coli [4], Pseudomonas aeruginosa [69] and P. putida [128, 140] were obtained. 
An overview of organic solvent-tolerant bacteria, which are able to withstand 
organic solvents with a log Pow between 2 and 5, is given in Table 2.1. It is 
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interesting to note that the naturally solvent-tolerant microorganisms were isolated 
from various sources such as polluted and nonpolluted soils, domestic wastewater, 
and the deep sea. 
Solvent-tolerant strain 
P. put/da IH-2000 
P.putida S I2 
P. putida DOT-T1 
P. putida Idaho 
P. puf/'da GM73 
P. puf/da KT2442 
P. puf/da F l 
P. putida CE2010 
P. puf/c/a PpGl-7T 
P. puf/cfa No.69-3 
P. aeruginosa PST-01 
P. aeruginosa PAOl 
P. aeruginosa LST-03 
P. aeruginosa PAK101 
P. aeruginosa PAK102 
P. mendocina K08-1 
P. mendocina LF-1 
Pseudomonas sp. strain LB400 
A. xylosoxydans A41 
A. xylosoxydans ssp. denitrificans Y0129 
A. eutrophus H850 
Flavobacterium sp. strain DS-711 
Rhodococcus sp. strain 33 
Bacillus sp. DS-994 
6. thuringiensis R l 
6. mycoides R3 
S. ceret/s R5 
£ co//JA300 
E. coli OST3121 
Solvent tolerated 
Toluene 
Toluene 
Toluene 
Toluene 
Toluene 
p-Xylene 
p-Xylene 
Toluene 
Toluene 
Heptanol 
Cyclohexane 
Hexane 
Toluene 
Hexane 
p-Xylene 
Dimethylphtalate 
Dimethylphtalate 
Cyclohexane 
p-Xylene 
Cyclohexane 
Hexane 
Benzene 
Benzene* 
Benzene 
Toluene 
Toluene 
Toluene 
p-Xylene 
p-Xylene 
log Pow 
2.5 
2.5 
2.5 
2.5 
2.5 
3.1 
3.1 
2.5 
2.5 
2.4 
3.2 
3.5 
2.5 
3.5 
3.1 
2.3 
2.3 
3.2 
3.1 
3.2 
3.5 
2.0 
2.0 
2.0 
2.5 
2.5 
2.5 
3.1 
3.1 
Reference 
49 
145 
116 
15 
67 
27 
99 
99 
128 
140 
98 
78 
97 
69 
69 
47 
47 
99 
99 
99 
99 
88 
104 
87 
57 
57 
57 
4 
4 
TABLE 2.1 Overview of organic solvent-tolerant bacteria. The tolerance to organic solvents is presented 
as the ability of the organism to survive in a water-organic solvent two-phase system. However, not in 
all cases (*) has this criterion been tested rigorously. Log Pow values as published by Laane ef al. in 
1986. 
Not surprisingly, many efforts were made to uncover the mechanisms behind 
solvent tolerance since the discovery of organic solvent-tolerant strains. Because 
the first mode of action of an organic solvent is to partition in the membrane, 
researchers initially focused on membrane changes. These membrane changes 
have also been discussed for non-tolerant strains such as E. coli [2, 48], but in this 
Chapter we will focus on solvent tolerance mechanisms of naturally solvent-tolerant 
Gram-negative bacteria. A schematic representation of the solvent tolerance 
mechanisms in solvent-tolerant bacteria is given Figure 2.1. 
CYTOPLASMIC MEMBRANE CHANGES 
Several response mechanisms at the level of the cytoplasmic membrane have been 
observed in reaction to the accumulation of organic solvents. These responses all 
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counteract the change in membrane fluidity and bilayer stability with the purpose of 
restoring membrane fluidity and membrane functions [144]. Mechanisms described 
include changes in the degree of saturation of membrane lipids [110, 146], 
changes in the composition of the membrane lipid headgroups [109, 115, 144], 
changes in the membrane lipid turnover [109], and c/s into trans isomerization of 
unsaturated membrane lipids [35, 146]. Of these mechanisms, the isomerization of 
the membrane lipids has been studied in detail by several researchers. 
Outer membrane 
Periplasm 
Inner membrane 
FIGURE 2.1 Schematic representation of organic solvent tolerance mechanisms of solvent-tolerant 
bacteria. To compensate for the accumulation of organic solvents in the membrane, solvent-tolerant 
bacteria modify the composition of their cytoplasmic membrane (A). This compensation will only be 
partial, and thus, in a dynamic process, solvents have to be removed continuously from the membrane 
by the active efflux of the organic solvent (B). In combination with a retarded influx of solvents due to 
modifications at the outer membrane (C), bacteria are able to withstand the organic solvents. 
The isomerization of the c/s double bond of an unsaturated fatty acid into the trans 
configuration increases the membrane ordering and subsequently decreases 
membrane fluidity. Isomerization of c/s-unsaturated fatty acids as a reaction to 
hydrocarbons has been described by Heipieper etal. in 1992. In P. putida P8 cells, 
grown in the presence of phenols, c/s-unsaturated fatty acids were isomerized into 
the trans configuration to survive high phenol concentrations. Isomerization of 
membrane lipids also takes place in solvent-tolerant strains as reaction to the 
addition of an organic solvent phase. In the solvent-tolerant bacterium P. putida 
S12 it was shown that the amount of frans-unsaturated fatty acids corresponds to 
the survival of the strain in the presence of organic solvents [146]. It seems that 
this energy-independent isomerization [21] of c/s-unsaturated fatty acids plays an 
important role in organic solvent tolerance, allowing the cells to survive the initial 
cell damage by organic solvents. 
The cti gene responsible for c/s into trans isomerization of membrane lipids in the 
solvent-sensitive P. putida P8 has been isolated by Holtwick etal. by complementing 
an isomerase-negative mutant. The deduced amino acid sequence of the cti gene 
showed no homology with other proteins [41]. In studies by Heipieper etal. it has 
been shown that f/ans-unsaturated lipids were formed in the presence of 
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chloramphenicol, indicating a constitutive enzyme system for cis into trans 
isomerization in P. putida P8 [39]. This was later confirmed by sequence analysis of 
the cti promoter region, revealing a Pseudomonas constitutive rpoD promoter 
sequence in this strain [41]. 
The cis-trans isomerase from Pseudomonas sp. strain E-3 seems to be located in the 
cytosol [101], although the characteristics of the purified isomerase are not typical 
for cytosolic proteins [100]. In a recent study, the cis-trans isomerase of 
Pseudomonas oleovorans Gpol2 was purified and determined to be located in the 
periplasm [108], confirming earlier observations [14]. Both isomerases act in vitro 
only on free unsaturated fatty acids and not on membrane phospholipids [101, 
108]. However, in vivo c/s-unsaturated fatty acids are esterified to phospholipids 
and therefore an additional protein was anticipated to play a role in cis into trans 
isomerization [101]. In Pseudomonas sp. strain E-3 this protein was determined to 
be located in the cell envelope [101]. Moreover, in P. oleovorans Gpol2 it was 
shown that organic solvents induced this protein, and it was speculated that it is a 
membrane-bound phospholipase [108]. 
The isomerization of c/s-unsaturated fatty acids appears to be heme-catalyzed 
[42]. Evidence from isomerase-negative mutants demonstrated the involvement of 
a protein of the cytochrome c type in the isomerization of c/s-unsaturated fatty 
acids. It was speculated that this protein was involved in the transport of heme over 
the cytoplasmic membrane [42]. Transposon mutants in this study, which were 
disrupted in the cytochrome c operon, were unable to isomerize c/s-unsaturated 
fatty acids. Interestingly, similar observations concerning the involvement of the 
cytochrome c operon in solvent tolerance had been obtained previously with 
solvent-sensitive transposon mutants of P. putida IH-2000. The absence of 
isomerase activity was not determined in this study [40], but a relation between 
these two aspects may exist. 
Several mutants of Pseudomonas became solvent-sensitive because of the lack of 
isomerase activity [115]. However, other strains were shown to be sensitive toward 
organic solvents and still capable of isomerase activity [110, 115]. Therefore, the 
cis-trans isomerization of unsaturated fatty acids is unlikely to be the only 
mechanism for solvent tolerance. Isomerization of unsaturated fatty acids has also 
been reported as a reaction to starvation [30], elevated temperatures [102], heavy 
metals [35], antibiotics [58], and excess salinity [79]. Because an increased 
amount of frans-unsaturated fatty acids decreases membrane fluidity, it can be 
concluded that bacteria use isomerization of the unsaturated lipids to counter the 
increased fluidity due to general stress conditions, including organic solvents. 
MECHANISMS OF ORGANIC SOLVENT TOLERANCE 15 
OUTER MEMBRANE CHANGES 
The majority of the isolated solvent-tolerant bacteria are Gram-negative. This 
observation is in agreement with the fact that Gram-negative bacteria are more 
resistant to deleterious lipophilic compounds [31, 50, 141]. No differences between 
Gram-negative and Gram-positive bacteria were observed in regard to the critical 
concentration of organic solvent dissolved in the cytoplasmic membrane [141]. 
Therefore, the existence of an outer membrane in Gram-negative bacteria could 
explain the differences in tolerance toward organic solvents. The outer membrane is 
considered to be a highly porous shield that allows small hydrophilic molecules to 
pass via pores, and it has a surprisingly high transfer resistance toward 
hydrophobic molecules [96]. A few studies have described changes at the level of 
the outer membrane as a result of the presence of organic solvents. Several 
researchers described the stabilization of the outer membrane by magnesium and 
calcium ions resulting in an increased solvent tolerance [51, 116, 144]. Changes in 
the outer membrane, as a response to the presence of organic solvents, were 
described at the level of lipopolysaccharides (LPS) and proteins. 
Modification of the outer membrane in Gram-negative bacteria has often been 
related to the LPS composition. Aono and Kobayashi suggested that an increased 
LPS content in solvent-tolerant mutants of £ coli K-12 resulted in a reduction of 
the cell envelope's hydrophobicity [3]. A similar reduction in the hydrophobicity of 
the cell envelope was observed in the organic solvent-tolerant P. putida S12 after 
adaptation to organic solvents [144]. These suggested changes in the LPS 
composition have indeed been found in the solvent-tolerant P. putida Idaho. 
Exposure of these cells to o-xylene resulted in the elongation of the saccharide 
chain of the LPS [110]. 
Other changes at the level of the outer membrane have been related to the 
membrane-embedded porins. OprL is a peptidoglycan-associated outer membrane 
lipoprotein (Pal) and was involved in the stabilization of the cell envelope and 
morphology [119, 120]. Mutants of P. putida DOT-TIE lacking the porin OprL 
became hypersensitive to organic solvents [119], most likely because their 
membrane structure was impaired. Similar results were observed in solvent-
sensitive mutants of P. aeruginosa lacking the porin OprF [74]. It was suggested 
that in P. aeruginosa organic solvents normally should enter the cell by passing 
through the OprF porin. However, OprF and OprL both are bifunctional porins that 
not only serve as diffusion porin but are also required for maintaining the structural 
integrity of the bacterial membrane [156]. Thus, in analogy with the OprL porin in 
P. putida, solvent sensitivity in P. aeruginosa could be due to the decreased stability 
of the membrane. Similar results concerning the involvement of a porin were 
obtained by Aono et al. in 1997. A repressed OmpF synthesis resulted in solvent-
tolerant mutants of £ co//[3]. Recently, however, Asako et al. showed that organic 
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solvent tolerance in E. coli was independent of OmpF levels and that the higher 
tolerance toward solvents was due to an elevated level of the acrAB efflux system 
[10]. In 1991, Hengge-Aronis and coworkers tested the resistance of £ coli to toxic 
compounds that affect the integrity of the membrane, proteins, and DNA. In their 
experiment stationary-phase cells were shown to exhibit better survival than log-
phase cells after treatment with 0 .1% toluene. Moreover, rpoS mutants were clearly 
more sensitive to toluene than wild-type cells were. From a present-day 
perspective, one could speculate that acrAB is involved since these genes are 
stationary phase induced [80] and are regulated by RobA [91], which in turn is 
under RpoS control [Hengge-Aronis, R., personal communication]. 
The specific roles of the various porins, the LPS content, and the composition of the 
outer membrane have not been clarified yet. It has been speculated that alterations 
at the level of the outer membrane prevent the rapid influx of organic solvent, 
allowing the cells to adapt to the extreme environment and to induce the necessary 
resistance mechanisms [17]. 
ACTIVE EFFLUX OF ORGANIC SOLVENTS 
The exceptional resistance of solvent-tolerant bacteria toward a wide variety of 
deleterious organic solvents cannot be explained solely by the mechanisms as 
described above. These mechanisms would allow the cells to retard the rapid influx 
of solvents in the cytoplasmic membrane. Nevertheless, despite the decreased 
accumulation rate of organic solvents in the membrane, similar equilibrium 
concentrations will eventually be reached. Therefore, it was anticipated that a 
longer-lasting active efflux system had to play a critical role in organic solvent 
tolerance [144]. An active efflux system is able to extrude organic solvents from the 
membrane to decrease the toxin concentration below its critical concentration in 
the membrane. This allows the survival of the bacterium in the presence of high 
concentrations of organic solvents. 
In 1996, Isken and de Bont were able to determine the active removal of 
nonmetabolizable 14C-labeled toluene from the solvent-tolerant bacterium P. putida 
S12. It was found that the amount of toluene was 50% lower in toluene-induced 
cells compared to the amount in noninduced cells. Furthermore, it was determined 
that the addition of the respiratory chain inhibitor potassium cyanide and the 
proton conductor carbonyl cyanide m-chlorophenylhydrazone increased the 
accumulation of toluene, suggesting the energy-dependent export of toluene in P. 
putida S12 [55]. Similar results were obtained by Ramos ef ai. in 1997 by 
measuring the extrusion of 14C-labeled 1,2,4-trichlorobenzene, as a 
nonmetabolizable analog for toluene, in the solvent-tolerant bacterium P. putida 
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DOT-TIE [115]. This confirmed the presence of energy-dependent efflux of organic 
solvents in solvent tolerance. 
An attempt to clone the genes for the energy-dependent efflux of toluene in P. 
putida S12 was undertaken [see Chapter 3]. Transposon mutants that were sensitive 
to toluene were constructed, which made it possible to clone and sequence the 
genes responsible for toluene efflux. The deduced amino acid sequences of the 
isolated srp genes showed strong homology with an efflux system of the 
resistance/nodulation/cell division (RND) family [95, 107]. These results 
demonstrate that indeed an efflux system in a solvent-tolerant bacterium is 
involved in the resistance toward uncharged lipophilic compounds such as toluene 
and xylene. 
The involvement of efflux in solvent tolerance was confirmed with the isolation of 
the ttgB gene and the mepABC genes in the toluene-tolerant P. putida DOT-TIE 
[117] and in the toluene-tolerant variant of P. putida KT2442 [27], respectively. 
Moreover, Kim etal. reported in 1998 that a transposon insertion in a protein of the 
RND family resulted in a P. putida mutant with a solvent-sensitive phenotype [67]. 
It is generally accepted that efflux pumps of the RND family are constructed in such 
a way that they traverse both the cytoplasmic and the outer membrane. Genetic 
and biochemical evidence supports the notion that the proton motive force is 
necessary for functioning of RND-type efflux pumps. In the reported efflux systems 
the inner membrane protein (RND protein) was thought to be a putative 12-
transmembrane-segment transporter protein that is attached, via a membrane 
fusion protein (MFP) belonging to the MFP family, to an outer membrane protein 
(OMP) [22, 124]. The OMP is thought to be an outer membrane channel to 
circumvent the outer membrane barrier, allowing the pumped molecule to be 
released into the medium [22]. Various toxic substrates are excreted from the cell 
membrane by RND-type transporters [see Table 2.2 for an overview of some 
representatives of the RND family]. These efflux systems are involved in the export 
of antibiotics, metals, organic solvents, and oligosaccharides involved in nodulation 
signaling [95, 107]. 
SOLVENT EFFLUX SYSTEMS VERSUS MULTIPLE ANTIBIOTIC RESISTANCE 
A close correlation between antibiotic and solvent tolerance has been demonstrated 
by Aono et al. in 1995. In this study cyclohexane-tolerant mutants of E. coli 
displayed an improved tolerance toward low levels of antibiotics [6]. A similar 
correlation between organic solvent tolerance and multiple drug resistance was 
observed by Isken etal. in 1997. In the naturally solvent-tolerant strain P. putida 
S12 it was demonstrated that cells, with a solvent-tolerant phenotype, were more 
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resistant toward multiple antibiotics. However, cells grown in the presence of 
antibiotic did not show an increased tolerance toward organic solvents [58]. These 
results can be explained in at least three different ways. First, the increased 
multiple antibiotic resistance can be the result of the active efflux as a result of the 
induction of the solvent transporter. Second, the solvents can be able to 
aspecifically induce an antibiotic efflux system. Third, the increased resistance can 
be the result of other mechanisms induced by organic solvents preventing the influx 
of the toxic compound. 
Efflux protein 
MFP 
SrpA 
MepA 
TtgA 
MexA 
MexC 
MexE 
AcrA 
RND 
SrpB 
MepB 
TtgES 
Ttg3 
MexB 
MexD 
MexF 
AcrB 
OMP 
SrpC 
MepC 
TtgC 
OprM 
OprJ 
OprN 
TolC 
Organism 
P. putida 
P. putida 
P. putida 
P. putida 
P. aeruginosa 
P. aeruginosa 
P. aeruginosa 
E. co// 
Substrate 
Solvents 
Toluene, p-xylene, 
octanol, ethylbenzene, 
propylbenzene, 
cyclohexane, hexane 
Toluene, p-xylene, 
cyclohexane 
Toluene, m-xylene, 
1,2,4-trichlorobenzene 
Toluene 
Toluene, p-xylene, hexane 
p-Xylene, hexane 
p-Xylene 
Hexane, cyclohexane 
Antibiotics 
Tc, PenG, Ery, 
Nov, Amp 
Tc, Cm, Amp 
ND 
Tc, Cm, PenG, 
Ery, Nov, Carb, 
Tc, Cm 
Cm 
Tc, Cm, PenG, 
Ery, Nov, Amp, 
Rif 
Rif 
Reference(s) 
6 3 , 6 4 
27 
117 
67 
76, 77, 78, 
112 
78, 114 
78 ,85 
8 1 , 152 
TABLE 2.2 RND-type efflux systems in Gram-negative bacteria involved in efflux of organic solvents and 
drugs. Some compounds are expected to be substrates based on solvent-sensitive phenotype or 
decreased MIC for transposon mutants. Abbreviations: MFP, membrane fusion protein; RND, inner 
membrane (transporter) protein; OMP, outer membrane protein; Tc, tetracycline; Cm, 
chloramphenicol; PenG, penicillin G; Ery, erythromycin; Nov, novobiocin; Amp, ampicillin; Carb, 
carbenicillin; Rif, rifampin; ND, not determined. 
Indeed, the AcrAB efflux pump of E. co//' was involved in resistance toward 
antibiotics and solvents [152]. It appears that the transcriptional activator marA 
[9], soxS [92], and robA [91] mediate this phenotype by upregulating the acrAB 
locus. Moreover, a toluene-sensitive transposon mutant of P. putida DOT-T1, with 
an insertional inactivation in the ttgB gene, was more susceptible to several 
antibiotics, including tetracycline, chloramphenicol, and ampicillin [117]. Similar 
results were obtained with an insertion mutant of a toluene-resistant variant of P. 
putida KT2442 [27]. Inactivation of the MepABC efflux system resulted in a solvent-
sensitive phenotype with a concomitant increase of sensitivity toward antibiotics. It 
was demonstrated that resistance toward toluene and high concentrations of 
antibiotics in this strain occurs only in a toluene-tolerant variant and not in wi ld-
type cells [27]. Toluene and multiple antibiotic resistance in this strain were 
suggested to be due to the upregulation of the MepABC efflux system. In P. 
aeruginosa the three efflux systems MexAB-OprM, MexCD-OprJ, and MexEF-OprN 
are involved in both multiple antibiotic resistance and solvent tolerance [78]. 
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Moreover, organic solvent-tolerant mutants of P. aeruginosa were multidrug-
resistant due to mutations in the regulator MexR [113]. This resulted in the 
overexpression of MexAB-OprM and an increased expression of MexEF-OprN. 
Induction mechanisms of efflux systems for antibiotics in Gram-negative bacteria 
have not been studied in detail. Therefore, it is at present difficult to speculate on 
solvent-induced expression of multiple antibiotic efflux systems. 
FUTURE PROSPECTS 
Solvent-tolerant bacteria hold considerable promises in the field of applied 
biotechnology. Two possible applications, namely solvent-tolerant bacteria as cell 
factories [17, 116] and as the source for solvent-stable enzymes [97, 98], have 
been demonstrated. With the genetic uncovering of solvent tolerance mechanisms 
and their regulation, it becomes possible to use solvent-tolerant bacteria as 
production hosts in biotechnological processes. Furthermore, it has to be seen in 
the near future what the exact relation is between solvent tolerance and multiple 
drug resistance. 
IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF AN EFFLUX 
PUMP INVOLVED IN PSEUDOMONAS PUTIDA S 1 2 SOLVENT TOLERANCE 
Jasper Kieboom, Jonathan J. Dennis, Jan A. M. de Bont, and Gerben J. Zylstra 
SUMMARY 
Bacteria able to grow in aqueous-organic two-phase systems have evolved 
tolerance mechanisms to the toxic effects of solvents. One such mechanism is the 
active efflux of solvents from the cell, preserving the integrity of the cell interior. 
Pseudomonas putida S12 is tolerant to a wide variety of normally detrimental 
solvents due to the action of such an efflux pump. The genes for this solvent efflux 
pump were cloned from P. putida S12 and their nucleotide sequence determined. 
The deduced amino acid sequences encoded by the three genes involved show a 
striking resemblance to proteins known to be involved in proton-dependent 
multidrug efflux systems. Transfer of the genes for the solvent efflux pump to 
solvent-sensitive P. putida strains results in the acquisition of solvent tolerance. 
This opens up the possibilities of using the solvent efflux system to construct 
bacterial strains capable of performing biocatalytic transformations in normally 
toxic two-phase aqueous-organic systems. 
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INTRODUCTION 
The microbial transformation of hydrocarbons is important not only in 
environmental applications such as soil remediation and waste stream purification, 
but also in biocatalytic applications for the production of specialty chemicals. The 
metabolic pathways by which many of these compounds are degraded in various 
bacteria have been elucidated and in many cases the genes coding for the enzymes 
involved have been cloned and sequenced [159]. A major problem in applying 
hydrocarbon-degrading bacteria to industrial processes is their susceptibility to the 
toxic effects of the very substrate that the organism is utilizing as a carbon source. 
This is often due to accumulation of the hydrophobic compound in bacterial 
membranes, which can cause devastating effects on membrane structure [130, 
131]. A second problem in the application of catabolic pathways in the synthesis of 
fine chemicals is that many of the desired substrates of enzymatic reactions are 
sparingly soluble in water and thus may not be fully bioavailable to 
microorganisms. The use of solvent-tolerant bacteria allows the introduction of an 
organic phase to the medium, dissolving the desired substrate, and increasing the 
exposure of the cell to the substrate. 
Organic Solvent (s) 
Outer Membrane 
Periplasm 
Cytoplasmic Membrane 
FIGURE 3.1. Schematic representation of essential features of solvent-tolerant bacteria. 
(A) Solvents diffuse to and preferentially partition to the cytoplasmic membrane where they cause 
disruptions in membrane functions by increasing membrane fluidity and affecting bilayer stability 
[131, 144]. (B) To compensate for these effects, solvent-tolerant bacteria modify the composition of 
the membrane either by isomerizing cis- into frans-unsaturated fatty acids from the membrane lipids 
[55, 146] or by changing the headgroup composition [115, 144]. This compensation will only be 
partial and thus in a dynamic process, solvents have to be removed continuously from the membrane. 
(C) Removal to a certain extent may be by degradation [116]. (D) Very recently, on the basis of whole 
cell experiments, evidence was obtained that an unprecedented energy-dependent export system for 
hydrophobic solvents is in operation [55]. (E) In combination with a retarded influx of solvents due to 
modifications at the outer membrane [74, 110], the new efflux pump functions as the key factor in 
solvent tolerance. 
Many different mechanisms have been described that contribute to solvent tolerance 
[Figure 3.1] but despite these efforts no comprehensive overview is available to 
explain the physiological response of microorganisms to toxic organic solvents [see 
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Chapter 2]. We have been investigating the ability of Pseudomonas putida S12 to 
withstand toxic concentrations of toluene and other organic solvents [145]. This 
organism has evolved at least two mechanisms to resist the accumulation of 
hydrophobic solvents in the membrane or the interior of the cell. One key observation 
was the detection of trans rather than c/s-unsaturated fatty acids in the membrane of 
the solvent-tolerant bacterium upon exposure to solvents [34, 36]. The conversion of 
cis- to frans-unsaturated fatty acids by a direct isomerization alters the packing of the 
phospholipids in the bacterial membrane. This results in a change in membrane 
fluidity, making the membrane less likely to allow solvents to partition into it, 
decreasing the detrimental effects on the membrane due to solvent partitioning, and 
thus increasing the solvent tolerance of the cell [60]. Recently it has been shown that 
a second mechanism of solvent tolerance is possessed by P. putida SI2. This energy-
dependent efflux system for solvents such as toluene [55] may function in a fashion 
similar to that for multidrug efflux pumps found in many antibiotic-resistant 
microorganisms. Thus, P. putida S12 employs at least two mechanisms for active 
defense against the detrimental effects of solvents: one functioning to keep solvents 
out of the interior of the cell and a second functioning to prevent solvents from 
partitioning into the cell membrane. 
In this Chapter we describe the construction of transposon mutants of P. putida S12 
that have lost the solvent-tolerant phenotype. This allowed the cloning of the genes 
responsible for a solvent efflux pump that is involved in the ability of P. putida S12 
to withstand toxic concentrations of organic solvents. The nucleotide sequence of 
the genes involved was determined and their relationship to other bacterial efflux 
systems is discussed. 
MATERIALS AND METHODS 
Bacterial strains, plasmids, media, and growth of strains 
P. putida S12 [33] is the wild-type strain capable of growth at saturated solvent 
concentrations [145] and is the object of the present investigation. P. putida JK1 is 
a solvent-sensitive mutant of P. putida S12 derived in the present work by 
transposon mutagenesis with Tn/Wod-KmO. P. putida JJD1, also derived in the 
present work, contains a kanamycin gene/ColEl origin cassette insertion in the 
genome of P. putida S12. The solvent-sensitive strain P. putida PPO200 is P. putida 
mt-2 cured of the TOL plasmid [160]. The artificial transposable element TnMod-
KmO [18] contains a kanamycin resistance gene and the ColEl origin of replication 
between Tn5 inverted repeats. The Tn5 transposase gene and an origin of transfer 
for conjugation are present outside the inverted repeats. Escherichia coli JM109 
(recAl endAl gyr A96 thi hsdR17 supE44 relAl A(lac-proAB) [F traD36 proAB 
laclqZAM15], [158]) was utilized as the host strain for all recombinant plasmids. 
The cloning vector pUC19 [158], the pGEM series of cloning vectors (Promega, 
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Madison, Wl), and the broad host range vector pUCP22 [150] were used for the 
construction of subclones. 
L broth [73] was used as complete medium. Minimal medium was prepared as 
described by Stanier etal. [135]. Solid media contained 2% agar. Ampicillin (100 
Hg/ml), kanamycin (50 ng/ml), or gentamicin (25 ng/ml) were added to the 
medium to maintain recombinant plasmids in E. coli. Gentamicin (25 ng/ml) was 
used to maintain the pUCP22 subclones in P. putida and kanamycin (250 ng/ml) 
was used in the selection of P. putida S12 transposon mutants. E. coli strains were 
routinely cultured at 37°C and P. putida strains were grown at 30°C. Growth of 
bacterial strains in the presence of various solvents (indicating solvent tolerance) 
was determined essentially as described by Weber et al. [145]. The experiments 
were conducted twice with duplicate samples each time. 
Generation and screening of TnMod-KmO insertion mutants 
The conjugatable suicide transposon donor Tn/Wod-KmO was introduced into P. 
putida S12 by triparental mating using pRK2013 as the mobilizing plasmid by 
established procedures [23, 66]. Kanamycin-resistant colonies were tested for the 
ability to grow on L agar plates in the presence of saturating vapor amounts of 
toluene. This was accomplished by placing the agar plates in a sealed glass 
desicator along with a small beaker containing toluene. Growth was scored after 12 
h at 30°C. 
DNA techniques 
Total genomic DNA from P. putida strains was prepared by the CTAB procedure 
[11]. Plasmid DNA was isolated by the alkaline-SDS lysis method of Birnboim and 
Doly [12]. DNA was digested with restriction enzymes and ligated with T4 ligase as 
recommended by the supplier (Life Technologies). DNA restriction fragment and 
PCR products were visualized by 0.7% or 1.0% agarose gel electrophoresis in 40 
mM Tris, 20 mM acetate, 2 mM EDTA buffer. DNA from agarose gels was isolated 
using the method of Vogelstein and Gillespie [142]. Plasmid DNA was introduced 
into either E. coli JM109 or P. putida JK1 cells by electroporation [19] using a Gene 
Pulser(Bio-Rad). 
All sequencing and PCR reactions were performed using a Gene Amp PCR System 
9600 (Perkin-Elmer). Nucleotide sequencing reactions were performed with 
purified double-strand plasmid DNA or PCR products using AmpliTaq FS DNA 
polymerase fluorescent dye terminator reactions (Perkin-Elmer) as recommended 
by the supplier. Sequencing products were detected using an Applied Biosystems 
373A stretch automated DNA sequencer (Applied Biosystems). Nucleotide 
sequence analysis was performed either with the Genetics Computer Group analysis 
package [20] or with the National Center for Biotechnology Information BLAST 
server [1]. PCR reactions for amplifying the region of genomic P. putida S12 DNA 
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containing the insertion point for the transposon were performed using Taq DNA 
polymerase (Perkin-Elmer). The reaction mixture (100 LII) was treated for 1 min at 
94°C followed by 25 cycles of 1 min at 96°C, 1 min at 55°C and 1 min at 72°C 
before finishing for 10 min at 72°C. Primers for this reaction were 5 ' -
CGTTTGCAACCGGTGAG-3' and 5'-TATCGGACGCAAACG-3' corresponding to 
positions 3735 to 3752 and 4238 to 4253 of the nucleotide sequence, respectively. 
RESULTS 
Isolation of solvent-sensitive mutants 
P. putida S12 was chosen for a molecular study of the basis of solvent tolerance due 
to the extensive physiological studies that have been performed on the strain [34, 
35, 37, 55, 144, 145, 146]. The organism can grow in the presence of a wide 
variety of normally toxic solvents with log Pow values ranging from 2.3 to 3.5 [Table 
3.1]. Initially, several solvent-sensitive transposon mutants were constructed using 
TnMod-KmO. P. putida SI2 mutants which are no longer tolerant to solvents were 
detected by the inability of kanamycin-resistant exconjugants to grow on L medium 
in the presence of saturated vapor concentrations of toluene as described under 
"Materials and Methods". Several toluene-sensitive mutants were obtained and one 
of these, designated strain JK1, was chosen for further analysis. Besides toluene, 
JK1 is sensitive to a number of other solvents with log Pow values less than or equal 
to 3.5 [Table 3.1], indicating that a single genetic trait is responsible for tolerance 
to all of the solvents tested. 
Growth of P. putida strains on L/acetate and 1% solvent 
Solvent 
Hexadecane 
Decane 
p-Cymene 
Propylbenzene 
Hexane 
Cyclohexane 
Ethyl benzene 
p-Xylene 
Octanol 
Toluene 
Dimethylphtalate 
Fluorobenzene 
Benzene 
Log P„w 
8.8 
5.6 
4.1 
3.6 
3.5 
3.2 
3.1 
3.0 
2.9 
2.5 
2.3 
2.2 
2.0 
S12 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
JK1 
+ 
+ 
+ 
+ 
-
-
-
-
-
-
-
-
-
JK1 (pUCP22) 
+ 
+ 
+ 
+ 
-
-
-
-
-
-
-
-
-
JK1 (pJD105) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
JK1 (pJD106) 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
-
-
-
TABLE 3.1. Growth of P. putida strains on L/acetate in the presence of various solvents. Strain JK1 is a 
transposon mutant of the genes for a solvent efflux pump. pJD105 and pJD106 are clones containing 
the three genes for the solvent efflux pump (srpABC) cloned into the vector pUCP22. pJD105 has the 
genes in the same orientation as the lac promoter on the plasmid while pJD106 has the genes in the 
reverse orientation. Different solvents (1% final concentration) were separately added to identical 
subcultures in L medium with 60 mM acetate during the early exponential growth phase. Growth of 
the culture was measured at various times after solvent addition with no continued growth indicating 
solvent sensitivity. A plus indicates growth with optical density (OD) > 0.7 after 24 h while a minus 
indicates no growth with OD < 0.1 after 120 h. 
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Cloning and analysis of the genes for solvent tolerance 
To characterize the genes for solvent tolerance in P. putida S12 in more detail, the 
region of the genome containing the transposon insertion in mutant JK1 was 
cloned. This was aided by the fact that the TnMod-KmO transposable element 
utilized in the construction of the mutants contains an origin of replication derived 
from plasmid ColEl. Total genomic DNA from JK1 was cleaved with BamHI, ligated 
to form circular molecules, and electroporated into E. coli JM109 with selection for 
kanamycin resistance. Since BamHI does not cleave the transposon the resulting 
clone, pJDIOl [Figure 3.2] must contain DNA from both sides of the transposon 
insertion. Approximately 11 kilobases of genomic DNA was cloned along with the 
transposon, which contains the origin of replication and the kanamycin resistance 
gene (2 kb). The point at which the transposon is inserted is only one kilobase away 
from one end of the BamHI fragment cloned from strain JK1. This being the case, a 
second, overlapping 4 kb Pst\ fragment was cloned from strain JK1 (designated 
pJD102, Figure 3.2). 
Ss *P 
B K , E C Bg Ss | C B 
pJDIOl U U 1 L 1 L ^ - J 
, 1 kb, P Ss 
|C B I p 
1 1 1 I I 
*P C Bg Ss , C 
pJD102 
pJD103 
»p Ss 
E C Bg Ss I C B IP 
pJD104 I I ^ ^ U I l_L 
*
p 
Ss I C B S s 
PJD105 ^ I I I I I 
*p 
Ss IC B S s 
pJD106 | II | | 
FIGURE 3.2. Restriction maps of the clones derived from the transposon and insertional mutant strains. 
A cartoon of the srpABC nucleotide sequence (GenBank accession number AF029405) is shown at the 
bottom, in proportion to the restriction maps and showing the positions of the genes relative to the 
restriction enzyme cutting sites. The triangles in the restriction maps of pJDIOl through pJD102 and 
the boxes in the restriction maps of pJD103 and pJD104 indicate the location of the inserted 
kanamycin resistance gene and the ColEl origin of replication in the cloned genomic DNA. The arrows 
next to pJD105 and pJD106 indicate the direction of transcription of the lac promoter from the vector 
pUCP22. The asterisk indicates that not all of the Pst\ sites were mapped in these plasmids. 
The cloned genomic DNA was initially analyzed by determining the nucleotide 
sequence to either side of the transposon insertion point using primers specific for 
either end of the transposon. Screening for similar nucleotide sequences in the 
GenBank database revealed a significant match with genes coding for multidrug 
resistance export pumps, consistent with the hypothesis that a solvent efflux pump 
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is a key solvent tolerance mechanism of P. putida S12. The complete nucleotide 
sequence of an operon into which the transposon had inserted was determined 
using a series of subclones and internal oligonucleotide primers. Both strands of a 
6.5 kb Sst\ fragment were sequenced in their entirety. To accurately determine the 
nucleotide sequence at the transposon insertion point, a 0.5 kb DNA fragment was 
amplified by PCR from the genome of the wild-type strain P. putida S12 using 
oligonucleotide primers flanking the transposon insertion point in strain JK1. A 
cartoon of the nucleotide sequence obtained is shown in Figure 3.2 to show the 
relationship of the open reading frames with the two clones pJDIOl and pJD102. 
The three open reading frames show significant homology to the three proteins that 
assemble to form proton-dependent multidrug resistance efflux pumps [95, 107] 
and thus the genes were labeled srp for solvent resistance gump. 
Complementation of P. putida JK1 
To prove that the three open reading frames detected in the cloned fragment at the 
point of insertion of the Tn/Wod-KmO transposon actually are responsible for solvent 
tolerance complementation experiments were performed. This required 
reconstruction of the operon since the clones obtained (pJDIOl and pJD102) 
contain the transposon mutagenized DNA. A Bgl\\-Sst\ kanamycin resistance 
cassette also containing the ColEl origin of replication from TnMod-KmO was 
inserted at the Bg/ll and Sst\ sites of a 6.7 kb C/al fragment derived from pJDIOl. 
The resulting plasmid (pJD103, Figure 3.2) was electroporated into P. putida S12 to 
construct a new mutation by site-specific reciprocal recombination. The resulting 
strain, JJD1, contains a kanamycin resistance gene adjacent to the srpABC genes in 
the genome. A 12 kb EcoRI genomic fragment containing the kanamycin/ColEl 
cassette was cloned from JJD1. This plasmid, designated pJD104 [Figure 3.2], 
contains the intact srpABC genes. A 6.5 kb Sst\ fragment was cloned from pJD104 
into the vector pUCP22 in both orientations with respect to the lac promoter. JK1 
containing either of these two plasmids, designated pJD105 and pJD106 [Figure 
3.2], regained solvent tolerance. JKl(pJD105), containing the srpABC genes in the 
same orientation as the lac promoter, regained tolerance to all of the solvents that 
the original strain, P. putida S12, was tolerant to [Table 3.1]. However, 
JKl(pJD106), containing the srpABC genes in the opposite orientation to the lac 
promoter, regained tolerance to only two solvents, hexane and cyclohexane, with 
log Pow values near the border of the tolerance phenotype. These results are 
consistent with the solvent tolerance phenotype being dependent on the level of 
expression of the srpABC genes. 
Transfer of the solvent tolerance phenotype 
P. putida S12 displays multiple physiological responses to organic solvents [see 
"Introduction"]. Intuitively, a solvent efflux pump would be the most important 
mechanism of solvent tolerance since it would be involved in actively removing 
solvents from the cell. Experiments were therefore performed to determine whether 
the solvent efflux pump by itself is capable of imparting the solvent tolerance 
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phenotype on other P. putida strains. The two plasmids pJD105 and pJD106 were 
electroporated into the normally solvent-sensitive P. putida PPO200. The resulting 
recombinant strains are able to grow on rich medium in a toluene-saturated 
atmosphere whereas the parent strain PPO200 with the vector pUCP22 could not 
[Figure 3.3]. PPO200(pJD106) grew slightly slower than PPO200(pJD105), 
probably due to the fact that the srpABC genes are expressed from the lac promoter 
in pJD105. In liquid culture, PPO200(pUCP22) could withstand concentrations of 
toluene up to 2.8 mM while both PPO200(pJD105) and PP0200(pJD106) showed 
tolerance to the toxic effects of toluene up to a concentration of 4.9 mM [Table 
3.2]. Neither of the recombinant strains was tolerant to a second phase of toluene. 
These experiments indicate that the solvent tolerance phenotype can be transferred 
to other bacterial strains and that higher levels of gene expression can enhance the 
tolerance. 
FIGURE 3.3. Photograph of the solvent-sensitive P. putida PPO200 plated on solid L medium in the 
presence of saturating vapor concentrations of toluene with and without the srpABC genes. Upper: P. 
putida PPO200(pUCP22), no growth. Lower left: P. putida PPO200(pJD105), good growth. Lower right: 
P. putida PPO200(pJD106), slow growth. 
DISCUSSION 
In the past several years solvent-tolerant microorganisms have been isolated directly 
from the environment [5, 15, 49, 110, 116, 145] or through the process of mutation 
of a solvent-sensitive strain [4, 6, 26]. It is evident that these organisms must 
therefore have specific adaptation mechanisms that impart the solvent tolerance. 
Physiological studies on microorganisms isolated from the environment that are 
naturally tolerant to high levels of organic solvents have revealed that many 
different factors may play a role [36, 144]. Naturally solvent-tolerant bacteria have 
been shown to alter the composition of the cell membrane by increasing the ratio of 
trans- to c/s-unsaturated fatty acids [146] or by changing the headgroup 
composition [115]. This change in the cell membrane produces a physical barrier, 
preventing solvents from entering the cell by decreasing membrane fluidity. This 
would not entirely prevent solvents from entering the cell, only slow down their 
ORGANIC SOLVENT EFFLUX 29 
diffusion into the cell and increase the time needed to reach equilibrium with the 
external environment. An intuitively better method of solvent tolerance would be to 
physically remove the solvent from the cell. One way of doing this would be to 
degrade the solvent but this would only be effective against low concentrations of 
solvents. Evidence was recently obtained that an energy-dependent export system 
for hydrophobic solvents functions to remove them from the interior of whole cells 
[55]. This solvent efflux pump should be a key element in solvent tolerance by 
naturally solvent-tolerant bacteria. The genes for such a solvent efflux pump in P. 
putida SI2 were identified via transposon mutagenesis to construct a solvent-
sensitive strain. The genes were cloned and sequenced and their role in solvent 
tolerance verified through complementation of the transposon mutation. The three 
genes involved were labeled srpABC for solvent resistance £ump. 
Toluene 
Concentration (mM) 
0.0 
0.7 
1.4 
2.1 
2.8 
3.5 
4.2 
4.9 
5.6 
Growth of P. putida strains on 
PPO200 (pUCP22) 
+ 
+ 
+ 
+ 
+ 
-
_ 
-
-
L Medium with Toluene 
PP0200 (pJD105) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
PP0200(pJD106) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
_ 
TABLE 3.2. Growth of P. putida PPO200, containing the cloned srp genes, on L medium in the presence 
of toluene. Toluene was added at different concentrations to identical subcultures in L medium during 
the early exponential growth phase. A plus indicates growth with optical density (OD) > 0.7 and a 
minus indicates no growth with OD < 0.1 after 24 h. 
The deduced amino acid sequences of the proteins encoded by the srpABC genes 
have extensive homology with those for proton-dependent multidrug efflux systems 
of the resistance/nodulation/cell division (RND) family [95, 107]. This family of 
efflux pumps is composed of three protein components that together span the inner 
and outer membranes of Gram-negative bacteria: an inner membrane transporter 
(SrpB analogues), an outer membrane channel (SrpC analogues), and a periplasmic 
linker protein (SrpA analogues). Members of this family are involved in export of 
antibiotics, metals, and oligosaccharides involved in nodulation signaling. Based on 
the work presented here, this family can be broadened to include a new class of 
efflux pump, involved in export of solvents. Dendrograms showing the phylogenetic 
relationship of SrpA, SrpB, and SrpC to other proteins involved in multidrug 
resistance are shown in Figure 3.4. The srp/ASC-encoded proteins show the most 
homology with those for the mex/A6/opr/W-encoded multidrug resistance pump 
found in Pseudomonas aeruginosa [28, 111]. SrpA, SrpB, and SrpC are 57.8, 64.4, 
and 58.5% identical to MexA, MexB, and OprM, respectively. The three 
dendrograms show that the Srp and the Mex proteins fall into a distinct class 
separate from but still closely related to the other members of the RND family of 
efflux pumps. The evolutionary relationship of the solvent tolerance pump to 
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multidrug resistance pumps is not surprising since they both function to export 
hydrophobic molecules from the cell. It is logical that a solvent efflux pump would 
have evolved since it would enable microorganisms to survive in close proximity to 
oil or coal deposits (a rich source of carbon and energy) in the environment. 
There have been several attempts to clone genes that are involved in solvent 
tolerance leading in many cases to the identification of a protein that is somehow 
involved in making the cell tolerant to a single solvent or to a group of related 
solvents. Most of these studies took place using E. coli that was forced under 
selective pressure to become solvent-tolerant. Mutations in a number of different 
genes can result in an increased tolerance to a particular chosen solvent, any one of 
which can allow the cell to grow in the presence of the solvent. Genes implicated in 
increased organic solvent tolerance of E. coli include the uncharacterized ostA (for 
organic solvent tolerance) [7], ahpC encoding alkylhydroperoxide reductase [26], 
robA encoding a global regulatory protein [91], and soxS encoding regulatory 
proteins controlling the superoxide response regulon [92]. These genes enhance the 
survivability of the organism in the presence of a particular solvent but are not 
responsible for solvent tolerance per se since they do not aid in understanding the 
true mechanism(s) of solvent tolerance found naturally in environmental isolates. 
This paper, however, represents the first example of cloning and characterization of 
genes for a major solvent tolerance system: a proton-dependent solvent efflux 
pump. 
We have shown that the cloned genes can be transferred to another P. putida strain 
with the concomitant gain of solvent tolerance by that organism. This has far 
reaching implications for industrial applications in the fine chemistry area. Existing 
and potential biocatalytic processes for compounds such as catechols, phenols, 
medium chain alcohols and enantiopure epoxides are suboptimal because the 
products formed are very toxic to normal microorganisms. Product accumulation to 
a concentration, which allows economic downstream processing is inherently 
prevented by the physical characteristics of these compounds. The ability, as 
demonstrated here, to take a normally solvent-sensitive strain and make it solvent-
tolerant will greatly enhance the ability of a given strain to perform a desired 
biocatalytic reaction in aqueous-organic two-phase system. 
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FIGURE 3.4. Dendrograms showing the levels of homology between the amino acid sequences of 
different proteins involved in proton-dependent efflux systems. A. Dendrogram of periplasmic linker 
proteins. B. Dendrogram of inner membrane transporter proteins. C. Dendrogram of outer membrane 
channel proteins. 
ACTIVE EFFLUX OF ORGANIC SOLVENTS BY PSEUDOMONAS PUT/DA 
S 1 2 IS INDUCED BY SOLVENTS 
Jasper Kieboom, Jonathan J. Dennis, Gerben J. Zylstra, and Jan A. M. de Bont 
SUMMARY 
Induction of the membrane associated organic solvent efflux system SrpABC of 
Pseudomonas putida S I2 was examined by cloning a 312 bp DNA fragment, 
containing the srp promoter, in the broad-host-range reporter vector pKRZ-1. 
Compounds that are capable of inducing expression of the srpfi.BC genes include 
aromatic and aliphatic solvents and alcohols. General stress conditions such as pH, 
temperature, NaCI, or the presence of organic acids did not induce srp 
transcription. Although the solvent efflux pump in P. putida S12 is a member of the 
resistance/nodulation/cell division family of transporters, the srpABC genes were 
not induced by antibiotics or heavy metals. 
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INTRODUCTION 
Several Pseudomonas putida strains possess an intrinsic resistance to a wide variety 
of structurally unrelated hydrophobic solvents [15, 49, 110, 145] that are lethal for 
most other Gram-negative bacteria. The susceptibility of bacteria to hydrophobic 
solvents is due to the accumulation of these compounds in the membrane [130, 
131], causing an adverse effect on its physicochemical properties. Solvent-resistant 
bacteria are able to counterbalance these effects through a variety of mechanisms 
mostly affecting the lipid content of the cell membrane: isomerizing c/s-
unsaturated fatty acids to the more rigid frans-unsaturated fatty acids [34, 36, 39], 
changing the head group composition of membrane fatty acids [144], increasing 
the phospholipid content [110], or increasing the basal rate of phospholipid 
synthesis [109]. These adaptations of the membrane are static, acting as a physical 
but still permeable barrier, and cannot explain the exceptional resistance of some 
P. putida strains to organic solvents. Therefore, it was anticipated that a dynamic 
system for exporting a broad range of structurally unrelated organic solvents from 
the bacterial membrane had to play an essential role in solvent tolerance [144]. 
Such an efflux system was indeed identified in P. putida S12 by means of an assay 
based on radiolabeled toluene [55]. The genes (srpABC) for this solvent efflux 
system were subsequently cloned, sequenced, and shown to impart the solvent-
resistant phenotype to solvent-sensitive P. putida strains [Chapter 3]. This efflux 
system shows strong homology to those of the resistance/nodulation/cell division 
family of transporters known to be involved in the extrusion of hydrophobic 
antibiotics, dyes, detergents, bile salts, heavy metals, and fatty acids from the 
membrane [95, 107]. 
Recently, several researchers also reported the involvement of active organic 
solvent efflux in solvent-resistant strains of Pseudomonas [27, 67, 78, 117]. 
Induction in Pseudomonas species of efflux systems involved in either multidrug 
resistance or solvent tolerance has not been studied in detail. 
RESULTS 
Construction of the lacZ reporter plasmid pKRZ-srp 
Plasmid isolation, restriction analysis, ligations, electroporation, sequencing and 
PCRs were performed according to standard methods as described in Chapter 3. 
The region of DNA encompassing the putative promoter region of the srp operon 
was amplified by PCR from pJDIOl [Chapter 3]. Primers for the PCR, were 5 ' -
GGGTCGACGCTGCTCTGGCGATGACC-3' and 5-GGTCTAGATCTGTCTCACGGTTTG-
GC-3', which amplify a 312 bp fragment corresponding to the region immediately 
upstream of the srpABC genes (positions -285 to +8, where 0 is the G of the GTG 
codon of srpA). The primers contain added recognition sites for Sal\ and Xba\, 
respectively. The PCR fragment was cloned into the lacZ reporter plasmid pKRZ-1 
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[122] cut with Xba\ and Sal\. The resulting plasmid, containing the sequence shown 
in Figure 4 .1 , was designated pKRZ-srp. 
Sail 
1 GTCGACTCGACGCTGCTCTGGCGATGACCTGGATGCCCCCGGCCTTGCCAACATTTTCAT 60 
61 CTGATTGGTTCATATCTTTCCTCTGCGCGTACGGCTGCGACCTATCACATTGGCCGCCAC 120 
SstI 
121 TGTAGAGCTCTCTGCCTCCGCTAGCCAGCCACACATCGCGAACGCCCCAATCGGTAAACC 18 0 
181 TCGACCAACGGCGGCTCAGGCTTGCTTGCATCGAGAGTATCGCATAATGGTAGACTCTAC 24 0 
241 CGCATTACGATTCAGCAATAGCCCCCGTCATGCGGGCAGAGAGATGGAGCCAAACCGTGA 300 
Xbal srpA M 
301 GACAGATCTAGA 312 
R Q 1 * 
FIGURE 4.1. Nucleotide sequence of the PCR-amplified Sal\-Xba\ fragment containing the srpABC 
promoter region. The terminal Sa/I and Xba\ sites were added by incorporating their cutting sites into 
the PCR primers. The amino acid sequences of srpA are shown extending outward on the right side of 
the PCR product. This fragment was inserted into pKRZ-1 so that the promoterless lacZ gene is 
downstream of the start codon of srpA. An asterisk indicates the stop codon inserted into srpA by the 
added Xba\ site. 
Basal levels of srp promoter activity 
P. putida S12 strains were grown to late log phase at 30°C in 200 ml of Luria-
Bertani broth [126] supplemented with 50 ug of kanamycin per ml. Cells were 
harvested by centrifugation at 4°C (16,000 x g, 10 min) and washed twice with 100 
mM potassium phosphate buffer (pH 7.0). The washed pellet was resuspended in 2 
ml of the same buffer and lysed by sonication for 5 min. Cell debris was removed 
by centrifuging the crude cell extract at 4°C and 20,000 x g for 20 min. p-
Galactosidase activity in the extracts was determined in triplicate by the method of 
Miller [86]. Total protein content in the extracts was determined in triplicate by the 
bicinchoninic acid method [133]. P. putida S12 containing either the promoter 
probe vector or pKRZ-srp was grown with no added inducers. (3-Galactosidase 
activity for the vector only was 0.9 ±0.1 nmol min -1 mg"1 while the basal activity for 
the clone containing the promoter region was 3.8 + 0.1 nmol min"1 mg"1. Similar 
levels of basal activity were observed when the strains were grown on minimal 
medium D [32] supplemented with 20 mM glucose as sole carbon and energy 
source and 50 ug of kanamycin per ml (0.8 and 3.9 nmol min"1 mg"1, respectively). 
Activation of the srp promoter over time 
To determine the time course for induction of the srp operon, B-galactosidase 
activity was measured as a function of time following exposure of P. putida S12 
containing either the promoter probe vector or pKRZ-srp. P. putida S12(pKRZ-srp) 
cells were grown in LB broth, and 3 mM toluene was added when the cells reached 
an optical density of 0.3 [Figure 4.2]. Induction of srp-lacZ expression was observed 
30 min after the addition of toluene and gradually increased over time. The 
maximum level of induction of the srp operon was observed when the cells reached 
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stationary phase. This clearly shows that exposure to one organic solvent result in a 
significant increase in transcription of the srp operon. 
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FIGURE 4.2. Activation of P. putida S12 srp promoter over time. The arrow indicates the addition of 3 
mM toluene. Cell density of P. putida S12(pKRZ-srp) in LB broth (•, control; • , induced cells) and p-
galactosidase activity (O, control; • , induced cells) were monitored over time. p-Galactosidase 
activity in the time scale experiments was determined in triplicate cultures by the method of Miller 
[86] by using chloroform and SDS to permeabilize the cells. 
Activation of the srp promoter by organic solvents 
The influence of toluene concentration on gene induction was determined by 
varying the amounts of toluene added to the cells in the early exponential phase. 13-
Galactosidase activity was measured in the late exponential phase of growth 
(optical density of 1.0 at 600 nm). As shown in Table 4 .1 , an increased amount of 
toluene added to the growth medium increases the level of srp-lacZ gene induction 
reaching a maximum at 6.0 mM. (The saturating limit of toluene in aqueous 
solutions at 30°C is 6.2 mM.) Induction by toluene thus results in a 15- to 17-fold 
increase in induction over basal levels. 
Several hydrophobic organic solvents including aromatic compounds, aliphatic 
compounds, and aliphatic alcohols were tested for their ability to induce the srp-
lacZ construct. As can be seen by the data presented in Table 4 .1 , all of the 
compounds tested are able to induce the srp genes. Certain aromatic compounds 
and aliphatic alcohols showed the highest levels of induction. The level of induction 
seems to correlate with increasing side chain length in the case of the alkyl-
substituted aromatics and with chain length in the case of the aliphatic alcohols (up 
to a 15- to 17-fold induction). 
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Chemical 
None 
Aromatic solvents 
Toluene 
Benzene 
Styrene 
p-Xylene 
Ethylbenzene 
Propylbenzene 
Aliphatic solvents 
Pentane 
Hexane 
Heptane 
Octane 
Nonane 
Alcohols 
1-Propanol 
1-Butanol 
1-Pentanol 
1-Hexanol 
1-Heptanol 
1-Octanol 
Concentration 
(mM) 
-
1.0 
2.0 
3.0 
4.0 
5.0 
6.0 
3.0 
3.0 
3.0 
3.0 
3.0 
1.0 
1.0 
1.0 
1.0 
1.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
p-Galactosidase activity 
(nmol min-1 mg of protein-1) 
3.8 ±0.1 
13.3 ±0.4 
36.5 ±0.6 
48.6 ±5.4 
57.0 ±7.5 
59.1 ±3.3 
64.3 ±6.6 
36.6 ±0.9 
32.2 ±3.4 
36.0 ±4.9 
47.3 ±4.1 
59.0 ±2.0 
30.1 ±0.8 
25.2 ±0.7 
34.2 ±1.2 
26.8 ±0.1 
23.7 ± 1.0 
22.2 ± 1.2 
25.1 ±0.5 
38.1 ± 1.2 
60.3 ±2.1 
66.1 ±0.2 
46.2 ± 1.2 
Induction 
(fold) 
1.0 
3.5 
9.6 
12.8 
15.0 
15.6 
16.9 
9.6 
8.5 
9.5 
12.4 
15.5 
7.9 
6.6 
9.0 
7.1 
6.2 
5.8 
6.6 
10.0 
15.9 
17.4 
12.2 
TABLE 4.1. Induction of (3-galactosidase expression in P. putida S12(pKRZ-srp) by solvents. P. putida 
S12(pKRZ-srp) cells were grown to late exponential phase (optical density of 1.0 at 600 nm) in LB 
broth. p-Galactosidase was determined in cell extracts by the method of Miller [86]. 
Antibiotics and heavy metals 
In Chapter 3 we showed that the srp operon shows a high level of similarity to 
proton-dependent multidrug efflux systems, which are know to be involved in the 
efflux of a variety of antibiotics and heavy metals [95, 107]. 
Firstly, the ability of certain antibiotics to induce the srp genes was tested. In initial 
experiments, we determined the MIC of each antibiotic by twofold serial dilution in 
LB broth. The inoculum was 2% of an overnight culture and growth at 30°C was 
determined after 12 h by measuring the optical density at 600 nm. The level of 13-
galactosidase activity was measured in the late exponential phase of cultures 
exposed to a level of each antibiotic, which resulted in approximately 50% decrease 
in growth rate. Growth of P. putida S12(pKRZ-srp) in the presence of 128 u.g 
chloramphenicol per ml, 128 u.g ampicillin per ml and 4 u.g tetracycline per ml 
resulted in only a twofold increase in induction over basal levels. No increase in 
induction over basal levels was observed in the presence of the other antibiotics 
tested: 256 ug penicillin G per ml, 256 ug novobiocin per ml and 4 ug rifampin per 
ml. 
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Secondly, the ability of heavy metals to induce the srp-lacZ fusion was determined. 
Cells of P. putida S12(pKRZ-srp) were grown in LB broth in the presence of six 
different heavy metals (added as chloride salts in a final concentration of 1 mM). 
Zinc, chromium, cobalt, nickel, and copper had no detectable effect on the srp 
promoter, while cadmium resulted in only a 1.6-fold increase in induction. 
Environmental factors 
General stress conditions such as NaCI, ethanol, and stationary phase are known to 
induce the AcrAB efflux system in Escherichia coli [80]. On this basis, it was 
suggested that a general regulatory mechanism exist in E. coli to prevent 
hydrophobic compounds from entering the bacterial cell. Such a general response 
was also observed in P. putida S12 in the case of the induction of c/'s- to trans-
isomerization of the membrane unsaturated fatty acids by environmental stress 
such as pH and heavy metals [37]. This change in fatty acid profile coincided with 
an increased resistance to organic solvents. To investigate whether the srp 
promoter activity was induced by these environmental factors, cells of P. putida 
S12(pKRZ-srp) were grown in LB broth under different conditions. Varying the 
growth temperature between 15 and 37°C and varying the pH between 6.0 and 8.0 
did not result in a change in srp promoter induction. High levels of inorganic ions 
(50 g of NaCI per liter) did not affect srp-lacZ expression, although the growth of P. 
putida S12(pKRZ-srp) under the conditions tested was severely inhibited by high 
levels of NaCI. 
Weber etal. [145] previously showed that incubating P. putida S12 with high acetic 
acid concentrations increased the survival of the strain after these cells were 
exposed to organic solvents. To determine if this was due to induction of the srp 
operon, the ability of acetate to induce this active efflux system for organic solvents 
was tested. P. putida S12(pKRZ-srp) was grown in LB broth in the presence of 20, 
40, and 60 mM acetic acid (pH 6.5). Under each concentration of acetate, only a 
twofold induction of the srp-lacZ construct was observed. These results suggest 
that the enhanced survival of acetic-acid-adapted cells is not due to activation of 
the SrpABC efflux system. 
DISCUSSION 
The data in this Chapter clearly shows that lipophilic, aromatic, and aliphatic 
solvents and alcohols induce the srpABC operon. The data suggests that neither 
aromaticity nor charge is required for organic solvents to act as an inducer. Unlike 
other efflux systems, the srpABC operon is not induced by environmental stress or 
heavy metals, demonstrating that the genes are specifically induced and are not the 
result of a general regulatory mechanism as described elsewhere for E. coli [80]. 
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The specific induction by solvents is underlined by the observation that 
hydrophobic antibiotics do not induce the SrpABC efflux system. P. putida S I2 only 
becomes more resistant to hydrophobic antibiotics by culturing cells in the 
presence of toluene, while P. putida S12 grown in the presence of antibiotics does 
not elicit the solvent-tolerant phenotype [58]. These observations suggest that 
hydrophobic antibiotics are removed from the membrane in solvent induced cells, 
while these hydrophobic antibiotics do not induce SrpABC-mediated efflux of 
hydrophobic organic solvents. 
Interestingly, Ramos era/, very recently reported the existence of at least two efflux 
pumps in the solvent-resistant P. putida DOT-TIE. One system apparently was 
expressed constitutively, while a second system was inducible [117]. 
Although the natural function of these resistance/nodulation/cell division-type of 
efflux systems has not been clarified yet, our data suggests that the SrpABC system 
plays a protective role in resistance to a wide variety of structurally unrelated 
hydrophobic compounds. Multidrug efflux systems in P. aeruginosa are not induced 
by known substrates of these efflux pumps [113], suggesting that the extrusion by 
these pumps of hydrophobic compounds is a nonspecific action. At present, the 
natural substrate(s) of these systems remains unknown. The SrpABC efflux system 
apparently does not have a natural function in excreting hydrophobic antibiotics 
because (i) solvent-sensitive mutants of P. putida S12 have normal levels of 
antibiotic resistance [Chapter 7] and (ii) the srpABC operon is induced solely by 
solvent stress [this Chapter]. 
IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF AN EFFLUX 
SYSTEM INVOLVED IN PSEUDOMONAS PUTIDA S 1 2 MULTIDRUG 
RESISTANCE 
Jasper Kieboom andJan A.M. de Bont 
SUMMARY 
In Chapter 3 we have described srpABC, an operon involved in proton-dependent 
solvent efflux in the solvent-tolerant Pseudomonas putida S12. In Chapter 4 we have 
shown that organic solvents and not antibiotics induce this operon. In this Chapter 
we have characterized a new efflux pump, designated ArpABC, on the basis of two 
isolated chloramphenicol-sensitive transposon mutants. The arpABC operon is 
involved in the active efflux of multiple antibiotics such as tetracycline, 
chloramphenicol, carbenicillin, streptomycin, erythromycin, and novobiocin. The 
deduced amino acid sequences encoded by the three genes involved show a striking 
resemblance with proteins of the resistance/nodulation/cell division family, which 
are involved in both organic solvent and multiple drug efflux. These findings 
demonstrate that ArpABC is highly homologous to the MepABC en TtgABC efflux 
systems for organic solvents and multiple antibiotics. However, ArpABC is not 
contributing to organic solvent tolerance in P. putida S12 but is solely involved in 
multidrug resistance. 
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INTRODUCTION 
It is well known that several strains within the family Pseudomonadacea show 
significant intrinsic resistance to a wide variety of structurally unrelated compounds 
such as antimicrobial agents and organic solvents [for reviews see 56, 95, 107, and 
Chapter 2]. In the case of Pseudomonas aeruginosa it was thought that a very low 
nonspecific permeability is the main cause of resistance to antibiotics [94]. In the 
case of Pseudomonas putida several changes at the level of the membrane 
contribute to organic solvent tolerance [56, 144]. Nevertheless, the exceptional 
resistance of Pseudomonadacea cannot be explained solely by low permeability of 
the outer membrane and changes at the level of the membrane. Not surprisingly, 
efflux systems have been identified that contribute to the exceptional resistance of 
these strains. These efflux systems, which belong to the resistance/nodulation/cell 
division (RND) family of transporters, consist of three components: the inner 
membrane transporter protein (RND protein) that is attached via a membrane 
fusion protein (MFP) to an outer membrane protein (OMP) [124]. The OMP is 
thought to be an outer membrane channel by which to circumvent the outer 
membrane barrier, allowing the pumped molecule to be released into the medium 
[22]. 
In Chapter 3 it was shown that the energy-dependent efflux of organic solvents was 
the key factor in organic solvent tolerance via the organic solvent transporter 
SrpABC [64]. Similar efflux systems for the active removal of organic solvents have 
been found in other P. putida strains. These RND-type of efflux systems, encoded 
by ttgABC [117], ttgDEF [89] and mepABC [27] are involved in the active efflux of 
toxic compounds such as toluene, p-xylene and styrene. In the case of the 
multidrug-resistant P. aeruginosa four efflux systems have been described: MexAB-
OprM [112], MexCD-OprJ [113], MexEF-OprM [68] and AmrAB [151]. These 
systems contribute to the energy-dependent efflux of a wide variety of antimicrobial 
agents such as p-lactams, tetracycline, fluoroquinolones and chloramphenicol. The 
interesting question now arises whether the RND-type transporters are able to 
export both antibiotics and solvents. Indications so far confirm that these pumps 
have dual pumping capacity. The mex-encoded efflux systems have recently been 
shown to be involved in the efflux of organic solvent in P. aeruginosa [78]. Moreover, 
solvent-sensitive mutants of P. putida DOT-TIE and P. putida KT2442 became more 
sensitive to antibiotics such as tetracycline, chloramphenicol and ampicillin, 
suggesting the active removal of multiple antibiotics by these efflux systems [27, 
117]. 
In this Chapter we have studied this aspect at the molecular level and have found a 
new efflux system in P. putida S12 that is involved in the intrinsic resistance of this 
strain to a wide variety of structurally unrelated antibiotics. Sequence analysis 
showed that this efflux system is highly homologous to the solvents/antibiotics 
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transporters MepABC and TtgABC. Moreover, we demonstrate that ArpABC in P. 
putida S12 is only involved in multidrug resistance and not in tolerance towards 
organic solvents. 
MATERIALS AND METHODS 
Bacterial strains, plasmids and growth of the strains 
P. putida S12 (ATCC 700801) [32], a wild-type strain capable of growth at 
saturated solvent concentrations [145], was the object of the present investigation. 
Mutant strains of P. putida S12 generated in this study and those generated 
previously are shown in Table 5.1. E. coli DH5a [158] was utilized as the host strain 
for all recombinant plasmids. The cloning vectors used and the plasmids generated 
in this study are shown in Table 5.1. Luria-Bertani (LB) broth [126] was used as 
complete medium. For electroporation cells were grown in 10 g/l trypthone and 5 
g/l yeast-extract. Solid media contained 2% agar. Ampicillin (100 u.g/ml), 
kanamycin (50 u.g/ml), gentamicin (10 ng/ml), and tetracycline (50 u.g/ml) were 
added to the medium to maintain recombinant plasmids in E. coli and P. putida. 
The E. coli strains were routinely cultured at 37°C and P. putida strains were grown 
at 30°C. 
Strain/plasmid Relevant characteristics Source or reference 
Strains 
P. putida S12 
P. putida JK1 
P. putida CM1 
P. putida CM2 
P. putida DM1 
E. coli DH5a 
Plasmids 
pTnMoc/-KmO 
pUC18 
pUC19 
pBBRlMCS 
pUCP22 
pKRZ-1 
pACYC184 
pJD105 
pCMlP 
pCM2P 
pCMlB 
pCMPE 
pCMCl 
pCMC2 
pKRZ-arp 
pTOl 
pSCl 
Ap r Cm r srpABC* arpABC* 
Apr Cm r srpBvTnMod-KmO 
Apr Cm5 arpBVJnMod-KmO 
Apr Cms arpCVTn/Wod-KmO 
Apr Cms srpBVTnMod-KmO arpA::tetA-oriR::arpB 
recAl 
Km', pMBl replicon 
Apr, cloning vector 
Apr, cloning vector 
Cmr, cloning vector, REP replicon 
Apr Gm r, cloning vector, pRO1600 replicon 
Kmr, promoter probe cloning vector 
Tcr, cloning vector 
pUCP22 containing srpABC 
Km' arpBC from chromosomal DNA of P. putida CM1 
Km' arpBC from chromosomal DNA of P. putida CM2 
Km r arpABC from chromosomal DNA of P. putida CM1 
pUC18 containing arpRA 
pUCP22 containing arpAB 
pUCP22 containing arpABC 
pKRZ-1 containing Parp lacZfusion 
Tcr Cms pBBRlMCS containing tetA-oriR 
lc' arpA::tetA-ohR::arpB, pMBl replicon 
32 
64 
This study 
This study 
This study 
158 
18 
Life Technologies 
Life Technologies 
70 
150 
122 
Calgene 
64 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
TABLE 5.1 Strains and plasmids used in this study. Ap, Cm, Km, Gm and Tc represent resistance (r) or 
sensitivity (s) to ampicill in, chloramphenicol, kanamycin, gentamicin and tetracycline, respectively. 
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Generation and screening of TnMo6-KmO insertion mutants 
The plasposon TnMod-KmO was introduced into P. putida S12 by electroporation 
[19]. Kanamycin-resistant transposon mutants were tested for the ability to grow 
on LB agar plates supplemented with 100 |ig/ml chloramphenicol and 50 |ig/ml 
kanamycin. Mutants were incubated at 30°C for 24 h. Mutants unable to grow in 
the presence of 100 |xg/ml chloramphenicol were selected. 
DNA techniques 
Total genomic DNA from P. putida strains was prepared by the CTAB procedure 
[11]. Plasmid DNA was isolated by the alkaline-SDS lysis method of Birnboim and 
Doly [12]. DNA was digested with restriction enzymes and ligated with T4 ligase as 
recommended by the supplier (Life Technologies). DNA restriction fragment and 
PCR products were visualized by 0.8% agarose gel electrophoresis in 45 mM 
Tris/borate, 1 mM EDTA buffer. DNA from agarose gels was isolated using the 
method of Vogelstein and Gillespie [142]. Southern analyses of chromosomal DNA 
and colony hybridizations were carried out according to Sambrook et al. [126]. 
Probes were labeled with DIG-dUTP using the PCR DIG Probe Synthesis Kit 
(Boeringher Mannheim) with the appropriate primers. Southern blot hybridizations 
were carried out by chemiluminescent detection under high-stringency conditions 
as described by the supplier (Boeringher Mannheim). Plasmid DNA was introduced 
into either E. coli DH5a or P. putida cells by electroporation [19] using a Gene 
Pulser(Bio-Rad). 
DNA sequences of both strands of the arpABC operon were determined by a 
combination of subcloning and primer walking. All sequencing and PCR reactions 
were performed using a Gene Amp PCR System 9700 (Perkin-Elmer). Nucleotide 
sequencing reactions were performed with purified double-strand plasmid DNA 
using AmpliTaq FS DNA polymerase fluorescent dye terminator reactions (Perkin-
Elmer) as recommended by the supplier. Sequencing products were detected using 
an Applied Biosystems 373A stretch automated DNA sequencer. Nucleotide 
sequence analysis was performed either with the Lasergene analysis package 
(DNASTAR) or with the National Center for Biotechnology Information BLAST server 
[! ]• 
Construction ofpCMC2 for complementation 
For the complementation experiments we reconstructed the arpABC operon since 
the clones obtained from P. putida CM1 and CM2 contain the transposon 
mutagenized DNA. Therefore, a 2.2 kb BamHI-Psfl fragment from pCMlB was 
cloned into the broad host range vector pUCP22, the resulting plasmid was 
designated pCMCl. A 2.3 kb Psfl-EcoRI fragment from pCM2P and a 2.0 EcoRI-Psfl 
fragment from pCMlP were ligated into Psfl-digested and alkaline dephosphatase 
treated pCMCl. The resulting plasmid pCMC2, containing the arpABC genes in the 
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same orientation as the lac promoter and was transferred to the mutant strains 
CM1 andCM2. 
Construction of suicide plasmid pSCl 
We amplified a 1289 base pair fragment containing the tetracycline resistance gene 
tetA from pACYC184. The primer 5-CGGAATTCTCATGTTTGACAGCT-3' and 5 ' -
GCGGTACCTCAGGTCGAGGTGG-3' contain added recognition sites for EcoRI and 
Kpn\, respectively. The reaction mixture (50 |xl) was treated for 10 min at 94CC 
followed by 35 cycles of 1 min at 94°C, 2 min at 55°C and 1 min at 72°C before 
finishing for 10 min at 72°C. This 1.3 kb EcoRI and Kpn\ fragment and a 0.7 kb 
Kpn\-Sst\ fragment from TnMod-KmO, containing the ColEl origin of replication, 
were ligated in EcoRI and Ssfl-digested pBBRlMCS, resulting in pTOl. The suicide 
plasmid pSCl was constructed by ligating a 2.0 kb EcoRI-Ssfl fragment from pTOl, 
a 3.0 kb Pst\-Sst\ fragment from pCMlP and a 3.0 kb Psfl-EcoRI fragment from 
pCMPE. 
Construction ofpKRZ-arp and determination of fi-galactosidase activity 
PCR reactions for amplifying the region of genomic P. putida S12 DNA containing 
the arp promoter were performed using Super Taq DNA polymerase (SphearoQ). 
The reaction mixture (50 u.1) was treated for 10 min at 94°C followed by 35 cycles 
of 1 min at 94°C, 1 min at 58°C and 1 min at 72°C before finishing for 10 min at 
72°C. Primers for this reaction were 5-CCGCTCGAGTACAACCTCATCTGGCCC-3' 
and 5-CGCTCTAGAATTGCATGAGGATCCTCG-3', which amplify a 276 base pair 
fragment corresponding to the region immediately upstream of the arpABC genes. 
The primers contain added recognition sites for Xho\ and Xba\, respectively. p~ 
Galactosidase activity in P. putida S12(pKRZ-arp) was determined by growing the 
cells to late-log phase at 30 °C in 10 ml LB broth supplemented with inducer. The 
P-galactosidase activity in these experiments was determined in triplicate by the 
method of Miller [86] using chloroform and SDS to permeabilize the cells. 
Determination of solvent tolerance and the minimal inhibitory concentration of antibiotics 
Solvent tolerance of the P. putida strains was determined in duplicate by growing 
the cells in 10 ml liquid LB medium in 100 ml flasks supplemented with 1 mM 
magnesium chloride. Toluene and p-xylene ( 1 % final concentration) were 
separately added to identical subcultures in LB/MgCb medium during the early 
exponential growth phase. The maximal aqueous benzene concentration was 
determined by adding increasing amounts of benzene. Growth of the cultures was 
measured 24 h after solvent addition with no continued growth indicating solvent 
sensitivity. The MIC for various antibiotics was determined by threefold serial 
dilution in LB broth in microtitre plates. The inoculum was 1% of an overnight 
culture and growth was determined by measuring the optical density at 600 nm 
after 36 h at 30°C. 
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RESULTS 
Isolation of chloramphenicol-sensitive mutants 
P. putida S12 is able to grow in the presence of a wide variety of normally toxic 
solvents and is relatively resistant to various antibiotics. Chloramphenicol-sensitive 
mutants were obtained by electroporating the transposon Tn/Wod-KmO in P. putida 
S12. Over 4000 kanamycin-resistant transposon mutants were constructed with an 
overall transformation efficiency for Tn/Wod-KmO of l , 5x l0 3 per |xg DNA. These 
mutants were tested for growth on solid LB medium supplemented with 100 u.g/ml 
chloramphenicol. Two chloramphenicol-sensitive mutants were isolated and were 
designated strain CM1 and CM2, respectively. 
p p 
p C M 1 P u 1 
p C M 2 P 
pCM1B 
p C M P E 
p C M C 2 
Bg B 
I , I 
1.0 kb 
BgB E P S E 
U I I I L_ 
1.0 kb 
arpR arpA arpB arpC 
FIGURE 5 .1 . Restriction maps of the clones derived from the transposon mutants CM1 and CM2. A 
diagram of the arp nucleotide sequence is shown at the bottom, in proportion to the restriction maps 
and showing the positions of the genes relative to the restriction enzyme cutting sites. The triangles in 
the restriction maps indicate the location of the inserted plasposon TnMod-KmO in the cloned 
genomic DNA. 
Cloning and analysis of the genes for chloramphenicol resistance 
To characterize the genes for chloramphenicol resistance in P. putida S12, the 
regions of the genome containing the transposon insertion in mutants CM1 and 
CM2 (both 5.8 kb) were cloned. From both mutants a clone was obtained from Pst\-
digested chromosomal DNA; the clones were designated pCMlP and pCM2P, 
respectively. Genomic DNA cut with BamHI from strain CMl was used to construct 
the 14.0 kb plasmid pCMlB. Plasmid pCMlB was shown to contain a complete 
operon, including the inserted Tn/Wod-KmO [Figure 5.1]. The nucleotide sequence 
of the operon was determined and screening for similar nucleotide sequences in the 
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GenBank database revealed a significant match with genes encoding for multidrug 
and solvent export pumps. We labeled the genes arp for antibiotic resistance rjump. 
A diagram of the nucleotide sequence obtained is presented in Figure 5.1 to show 
the relationship of the open reading frames with the three clones pCMlP, pCM2P 
and pCMlB. The deduced nucleotide sequence of arpA, arpB and arpC encode for 
proteins of 371, 1050 and 484 amino acid residues with a calculated molecular 
mass of 40.3, 112.8 and 52.8 kDa, respectively. Putative ribosome-binding sites 
precede the arpABC genes and a stable stem-loop structure was found downstream 
arpC and that may function as transcriptional terminator [Figure 5.2]. 
Construction of an arpABC mutant of P. putida JK1 
The presence of the solvent efflux pump SrpABC in P. putida CM1 and CM2 could 
mask the possible efflux of organic solvent by ArpABC. Therefore, to determine the 
role of ArpABC in solvent tolerance we decided to inactivate the arpABC gene cluster 
by site-specific reciprocal recombination in the solvent-sensitive transposon 
mutant P. putida JK1, creating a srp-arp double mutant. We electroporated P. putida 
JK1 with the suicide plasmid pSCl [Table 5.1] replacing part of arpA and arpB with 
the ColEl origin of replication and tetracycline resistance gene, resulting in the srp-
arp double mutant P. putida DM1. Recombination was confirmed by hybridization of 
P. putida DM1 chromosomal DNA with a probe for the tetA gene (data not shown). 
MIC in ng/ml for strain: 
Antibiotic 
Tetracycline 
Chloramphenicol 
Ampicillin 
Carbenicillin 
Streptomycin 
Erythromycin 
Rifampicin 
Polymyxim B 
Nalidixic Acid 
Novobiocin 
Penicillin G 
S12 
16 
64 
256 
1024 
32 
128 
64 
16 
256 
1024 
>4094 
CM1 
1 
16 
64 
4 
8 
8 
32 
8 
128 
64 
2048 
CM2 
2 
16 
128 
4 
8 
4 
32 
8 
128 
128 
4094 
CM1 (pCMC2) 
16 
128 
ND 
ND 
64 
128 
32 
8 
256 
1024 
ND 
CM2 (pCMC2) 
16 
128 
ND 
ND 
64 
256 
32 
8 
256 
1024 
ND 
TABLE 5.2 Determination of the MIC for various antibiotics for the P. putida strains. The MIC for 
antibiotics was determined in duplicate by threefold serial dilution in LB broth in microtitre plates. 
The inoculum was 1% of an overnight culture and growth was determined by measuring the optical 
density at 600 nm after 36 h at 30°C. ND; not determined. 
Complementation of P. putida mutants 
Complementation experiments were performed to prove that the TnMod-KmO 
inserted open reading frames detected in P. putida CM1 and CM2 are actually 
responsible for chloramphenicol resistance. These complemented strains regained 
chloramphenicol resistance similar to the wild-type levels [Table 5.2]. These results 
are consistent with the chloramphenicol-resistant phenotype being dependent on 
expression of the arpABC genes. We tested a variety of structurally unrelated 
antibiotics, which are known substrates for homologous efflux systems of the RND 
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family of transporters [95, 107]. Mutants CM1 and CM2 were not only sensitive to 
chloramphenicol but also to a number of other antibiotics [Table 5.2], 
demonstrating that a single genetic trait in P. putida S12 is responsible for 
resistance to the antibiotics tested. 
Solvent resistance of the P. putida strains. 
P. putida S12 is resistant to organic solvents mainly through the presence of a 
solvent efflux system [55, 64]. Therefore, it was determined whether the ArpABC 
efflux pump was involved in solvent resistance in P. putida S12. The antibiotic-
sensitive mutant strains CMl and CM2 were as resistant as the wild-type strain to 
benzene, toluene and p-xylene, whereas the srp-arp double mutant DM1 was as 
sensitive to organic solvents as the solvent-sensitive JK1 strain [Table 5.3]. These 
results indicate that the solvent resistance phenotype of P. putida S12 is not 
dependent on expression of the arpABC genes. 
Strain 
Solvent S12 CMl CM2 JK1 DM1 
6 mM 6 mM Benzene 
Toluene 
p-Xylene 
10 mM 
+ 
+ 
10 mM 
+ 
+ 
10 mM 
+ 
+ 
TABLE 5.3 Solvent tolerance of the P. putida strains. Solvent tolerance of the P. putida strains was 
determined in LB broth supplemented with 1 mM magnesium chloride. A plus indicates growth with 
1% organic solvent after 24 h at 30°C. 
Cloning and induction of the arpABC promoter 
To clone and sequence the promoter region and possible regulatory genes of the 
arp operon, we examined the region upstream the BamHI site of pCMlB. Therefore, 
we isolated approximately 3.0 kb P. putida S12 chromosomal DNA fragments 
digested with Psfl and EcoRI. These fragments were cloned into pUC18 cut with Psfl 
and EcoRI. We were able to isolate the plasmid from one colony out of 1200 by 
colony hybridization with a 0.7 kb BamHI-EcoRI fragment from pCMlB. This 
plasmid, pCMPE, contained the complete promoter region and an ORF (arpR) that 
is transcribed in the opposite direction to that of arpABC [Figure 5.1]. The arpR 
gene product (ArpR) is most similar to MepR (98.6% amino acid identity), which is 
a putative regulator of the MepABC organic solvent transporter [27]. The deduced 
nucleotide sequence of arpR encodes for a protein of 210 amino acid residues with 
a calculated molecular mass of 23.8 kDa. Sequence analysis of ArpR revealed a 
TetR family signature motif. A putative ribosome-binding site precede the arpR 
gene and a stable stem-loop structure was found downstream arpR and may 
function as transcriptional terminator [Figure 5.2]. Moreover, a putative ( i n -
dependent promoter consensus motif was found upstream the start op arpA. 
The P. putida S12 solvent transporter is solely induced by organic solvent [63]. In 
this light it is interesting to examine the induction of the multidrug transporter 
ArpABC. Therefore, the putative promoter region of the arpABC operon was 
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amplified by PCR and cloned in the iacZ reporter plasmid pKRZ-1 [122] cut with 
Xbal and Sail. The resulting plasmid, designated pKRZ-arp, was electroporated to 
P. putida S12. P. putida S12(pKRZ-arp) was grown in LB broth in the absence and 
presence of the antibiotics chloramphenicol, carbenicillin and erythromycin and the 
solvents toluene, p-xylene and hexane. 13-Galactosidase activity was subsequently 
assayed in late exponential phase (OD of 1.0 at 600 nm). No significant induction 
was observed by any of these compounds. 
GGGCGGCCACGCCCCTTAATGC^^^jAACACft^l^fiAACACTCCCTCACAftTCCTTAACAAAGTGTCATTTGCGCAGAGCAGGGCTCAAGCGCAGCATATCCAGCCCGGTGTCGA 3 6 0 
E n d arpR * K R L A P S L R L M D L G T D V 
RBS 
CCAGGGTGGTTCGCGCAACCCCGCGCTTGTAGAAGGCCCTTTCCGCCGCCTCGATGATCTGGGCACGGGTTTCCTGGGCTTCTTCTTTGGTTCGACGGACCATGGCAGTACAA|CCTC^flTC 960 
A L T T R A V G R K Y F A R E A A E I I A R T E Q A E E K T R R V M S t a r t arpR 
- 3 5 
TGGCCCGAACGCGCAGCGCGGGCGGGGAACGCTCCGAGGGCTCCTGTGCCGGGGCCTCTCGGATGAGCTAATCAAGCGCTGAGGGGTACCTGAGTACAACTCAGCAGTA|TTTACAlAACAA 10 80 
- 1 0 RBS 
CCATGAATGTAAG^ATAT^CCTTAGCAAGCTATTTATCCACCGGATAGCATTTTTTCCAGATCAAGATCTCTTCCATTACTCTTGAGCGTCTCCCTGCTCCAGCGACCCG^GG^TCCTCA 1 2 0 0 
S t a r t arpA 
TGCAATTCAAGCCAGCCGTTACCGCTCTGGTTTCCGCCGTCGCCCTGGCAACCCTGCTCAGTGGCTGTAAGAAAGAAGAAGCAGCGCCCGCGGCGCAGGCTCCTCAGGTCGGCGTCGTGA 1 3 2 0 
M Q F K P A V T A L V S A V A L A T L L S G C K K E E A A P A A Q A P Q V G V V 
RBS 
GATGCCACCAACGTCAAGAAGCCGGCCGGCCCTGATCAGGCCAACGCGGCGAAAGCAGACGCCAAAGC|GGAGJTAAACCATGTCGAAGTTCTTTATCGATCGCCCGATCTTCGCCTGGGTG 2 4 0 0 
R C H Q R Q E A G R P * E n d arpA S t a r t arpB M S K F F I D R P I F A W V 
GTATTGCTGGGTACCTTCGGTATCCTTGCCGCCGCGGGCTTCAGCATCAACACCCTGACCATGTTCGCCATGGTCCTGGCCATCGGCTTGCTGGTGGACGACGCCATCGTCGTGGTGGAG 3 6 0 0 
V L L G T F G I L A A A G F S I N T L T M F A M V L A I G L L V D D A I V V V E 
RBS 
GCTATCTTCTGGGTACCACTGTTCTTCGTCGCAGTGTCGTCGCTGTTCGGCAGCAAAGAGCCGGAAAAAGACGTCACCCCTGAAAATCCACGTTA1JGAGG]CTGGGCAATGACCAAGTCTT 5 5 2 0 
A I F W V P L F F V A V S S L F G S K E P E K D V T P E N P R Y E A G Q * E n d arpB 
S t a r t arpC M T K s 
AATCGGCGGATGTTGCCGCTGCTGAACAGGGCTGGCGCCAGTTCTTCCACGACCCGGCGCTGCAACAGCTGATCCAGACCTCGCTGGTCAATAACCGCGATCTGCGCGTCGCAGCGTTGA 57 60 
Q S A D V A A A E Q G W R Q F F H D P A L Q Q L I Q . T S L V N N R D L R V A A L 
TCGGCGACCGCCTGTCGCAGCTGACCAGCGAGGTCAACCTGTACAAGGCGCTTGGCGGTGGCTGGTACGAGCAGACCGGGCAGGCCAACCAGCAGGCATCGGTGGAAACACCGAAAGGCT 6 9 6 0 
I G D R L S Q L T S E V N L Y K A L G G G W Y E Q T G Q A N Q Q A S V E T P K G 
G A T C G G C C T T G T T A C A G C A C ^ J ^ ^ ^ P C T T A G C ^ ^ ^ ^ ^ B T G C T T T T T T A C T G G C T G T G C C G G C C A G T A T C T C T T G G C G A T T C A C C G T C G C R G C C A C C A C C G T A T T C G C G G G T G A A 7 0 8 0 
* End arpC 
FIGURE 5.2. Nucleotide sequence of the relevant portions of a 7313 bp fragment containing the arp 
genes. The deduced amino acid sequences of the encoded proteins are shown beneath the nucleotide 
sequence. Termination codons are indicated with an asterisk and putative ribosome binding sites and 
a putative a70-dependent promoter motif that resembles the E. coli consensus motif 5"-TTGACA-N(i5_ 
19)-TATAAT-3~ have been marked with boxes. Inverted repeat sequences are indicated in black boxes. 
An arrow indicates the position of TnMod-KmO in P. putida CMl and P. putida CM2 (position 3594 and 
5738 of the arpABC sequence, respectively). The GenBank accession number for the arp sequence is 
AF183959. 
DISCUSSION 
In this Chapter we describe the isolation and characterization of chloramphenicol-
sensitive mutants from the solvent-tolerant and multidrug-resistant bacterium P. 
putida S12. Two chloramphenicol-sensitive mutants were isolated and sequence 
analysis showed that both mutants were disrupted in the same operon. Multidrug 
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efflux systems play an important role in the intrinsic resistance of members of the 
family of Pseudomonadacea to a variety of antibiotics [see Table 5.4 for homology 
between ArpABC and other representatives of the RND-family of transporters]. At 
present four antibiotic efflux systems have been described in P. aeruginosa: MexAB-
OprM [112], MexCD-OprJ [113], MexEF-OprM [68] and AmrAB [151]. These 
systems are involved in the proton-dependent efflux of antimicrobial agents such as 
p-lactams, tetracyclines, fluoroquinolones and chloramphenicol. In P. putida 
TtgABC [117], MepABC [27] and the ArpABC efflux system described in this 
Chapter are involved in tolerance towards antibiotics such as tetracycline, 
chloramphenicol, carbenicillin, streptomycin, erythromycin and novobiocin. Our 
findings demonstrate that the ArpABC efflux system is a key mechanism in 
multidrug resistance in P. putida S12. 
Efflux system proteins 
Organisms 
P. putida 
P. aeruginosa 
E. co// 
N. gonorrhoeae 
MFP 
ArpA 
TtgA 
MepA 
TtgD 
SrpA 
MexA 
AmrA 
MexC 
MexE 
AcrA 
AcrE 
MtrC 
Identity 
100 
99.7 
99.2 
58.0 
57.1 
67.6 
37.4 
43.1 
29.6 
53.8 
50.6 
43.3 
RND 
ArpB 
TtgB 
MepB 
TtgE 
SrpB 
MexB 
AmrB 
MexD 
MexF 
AcrB 
AcrF 
MtrD 
Identity 
100 
99.9 
99.9 
62.2 
63.4 
78.1 
48.7 
48.4 
41.4 
65.4 
64.4 
46.6 
OMP 
ArpC 
TtgC 
MepC 
TtgF 
SrpC 
OprM 
-
OprJ 
OprN 
TolC 
-
MtrE 
Identity 
100 
99.6 
99.8 
56.6 
57.3 
69.4 
-
41.6 
28.4 
19.3 
-
39.7 
RP 
ArpR 
-
MepR 
-
SrpR 
SrpS 
MexR 
AmrR 
-
MexT 
AcrR 
EnvR 
MtrR 
Identity 
100 
-
98.6 
-
30.9 
27.3 
37.5 
32.2 
-
22.0 
37.6 
30.3 
33.0 
TABLE 5.4 Amino acid sequence identity (in %) between ArpABC and multidrug and solvent efflux 
proteins. MFP, membrane fusion protein; RND, efflux protein; OMP, outer membrane protein; RP, 
regulatory protein. Identity (matches over matches, mismatches and gaps) was calculated with the 
Lipman-Pearson algorithm using the deduced amino acid sequences of ArpA, ArpB, ArpC, and ArpR 
(GenBank accession no. AF183959); TtgA, TtgB and TtgC (AF031417); MepA, MepB, MepC, and MepR 
(AB008909); TtgD, TtgE and TtgF (PPY19106); SrpA, SrpB and SrpC (AF029405): SrpR and SrpS 
(AF061937); MexA and MexB (L I 1616); OprM (L23839); MexR (U23763); AmrA, AmrB and AmrR 
(AF147719); MexC, MexD, and OprJ (U57969); MexE, MexF and OprN (X99514); MexT (AJ007825); 
AcrA and AcrB (U00734); TolC (X00016); AcrR (U00734); AcrE and AcrF (AE000405); EnvR (X57648); 
MtrC (U14993); MtrD (U60099); MtrC (X95635) and MtrR (Z25797). 
Proton-dependent efflux systems also play an important role in organic solvent 
tolerance in Pseudomonas putida strains [27, 64, 117]. The first RND-type efflux 
system for toluene was isolated by Kieboom et al. in 1998 and was shown to be 
responsible for organic solvent tolerance in P. putida S12 [64]. The involvement of 
efflux systems in solvent tolerance was confirmed with the isolation of the ttgABC, 
ttgDEF genes from P. putida DOT-TIE [89, 117] and the mepABC genes from P. 
putida KT2442 [27]. Moreover, Kim et al. reported that a transposon insertion in a 
protein of the RND-family resulted in a P. putida mutant with a solvent-sensitive 
phenotype [67]. Surprisingly, other studies suggested that the isolated solvent 
transporter in P. putida was also involved in the active efflux of multiple antibiotics. 
A toluene-sensitive mep6VTn5 mutant of P. putida KT2442 was also sensitive to 
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ampicillin, penicillin G, erythromycin, novobiocin, and tetracycline [27]; and a 
toluene-sensitive ffgBVmini-Tn5'pr)0/4-Kmr mutant of P. putida DOT-TIE was 
sensitive to chloramphenicol, ampicillin and tetracycline [117]. With the 
construction of a srp-arp double mutant we were able to demonstrate that the 
ArpABC efflux system was not involved in organic solvent tolerance in P. putida S12. 
An interesting but yet not completely clear picture is now emerging from the 
studies on efflux pumps from pseudomonads with regard to both their substrate 
recognition and their induction patterns. The inherent problem in studying these 
aspects is that responses to doses of antibiotics or organic solvents must be 
monitored at the whole cell level. Both wild-type cells and mutants may or may not 
contain additional, and often unknown, pumps. Moreover, the rate of influx of 
compounds will depend on their chemical structure, while the cell may alter the 
composition of its cell envelope, thus further obscuring the explanation of results. 
Nevertheless, on the basis of this type of experimentation it is now possible to 
distinguish three types of proton-dependent efflux systems in pseudomonads on 
the basis of compounds expelled from the cell. To date it seems two efflux pumps 
have been described that are involved solely in the efflux of solvents and that 
appear not to be able to export antibiotics. This type of efflux pump includes 
SrpABC in P. putida S12 and TtgDEF in P. putida DOT-TIE and was shown to be 
induced by organic solvents [64, 89]. Most of the efflux systems characterized in 
pseudomonads, however, export both antibiotics and solvents. These systems 
include the constitutive TtgABC pump in P. putida DOT-TIE [117], the MepABC 
pump in P. putida KT2442 [27], and the Mex efflux systems in P. aeruginosa [78]. 
The third type is the ArpABC system reported here, which is involved in antibiotic 
resistance but not in solvent tolerance as shown by the phenotype of the srp-arp 
double mutant. However, a note of caution in identifying ArpABC as an antibiotic 
and not as a solvent-removing system is appropriate. A solvent pump has to 
operate at a higher speed than an antibiotic pump due to considerable higher influx 
of hydrophobic solvents compared to the influx of antibiotics. Toluene may be 
present at 5 mM in the aqueous phase, while antibiotics usually remain below 1 
mM and it is to be expected that antibiotics will diffuse more slowly into the cell 
than uncharged, small solvent molecules do. Consequently, solvent efflux pumps 
may have to generate an efflux that is probably 10-100 times higher than the efflux 
created by the antibiotic pumps. If the expression level is not affected by the 
presence of solvent as substrate, as is the case for the ArpABC system, then the 
solvent-pumping ability may not be registered at the whole cell level. We have tried 
to overcome this pitfall by using benzene as test solvent and by employing it at 
different concentration. This method should be relatively suitable to detect minor 
contributions to solvent pumping, but nevertheless, no effect of the presence of 
ArpABC on benzene sensitivity was observed. 
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The grouping of the known Pseudomonas efflux pumps according to their pumping 
activity for either solvent and/or antibiotics is not supported by the molecular 
structure of these pumps. The ArpB, TtgB and MepB proteins are almost identical 
at the amino acid level, which is quite surprising because they have been identified 
in strains isolated from 3 very different locations. Also their A and C components 
are almost identical. ArpB differs only in one amino acid from TtgB (Ala-544 to 
Gly-544), while compared to MepB it differs 3 amino acids (Ala-533 to Thr-533, 
Ala-544 to Gly 544, and Glu-692 to Ala-692). On the basis of the MexB membrane 
topology [29] it is expected that Ala-544 is located in a putative transmembrane 
segment, whereas Ala-544 and Glu-692 are periplasmatic. These observations 
would lead to the conclusion that Gly-544 might be a key amino acid in interactions 
with antibiotics. However, till date the substrate-binding domain of RND-type of 
proteins has not been identified. 
Alternatively it might be argued that MepABC and TtgABC are present at higher 
levels in their respective hosts. For P. putida KT2442 it was anticipated that the 
mep operon was overexpressed in the toluene-tolerant variant TOL. Possibly a 
similar adaptation phenomenon has taken place already during the isolation of 
strain P. putida DOT-TIE. Therefore, in both strains, a high transcription level of the 
efflux operons may result in a high solvent efflux, required for the cell to survive in 
the presence of toluene. Similar results were reported for the mexAB-oprM efflux 
system in P. aeruginosa. In this strain a single substitution in the mexR regulator 
resulted in the overexpression of MexAB-OprM resulting in an increased multidrug 
resistance and organic solvent tolerance [75, 78, 113]. 
In summary, the intrinsic resistance of P. putida S12 to multiple antibiotics is due 
to the efflux of these components by ArpABC. Whether, ArpABC in P. putida S12 is 
unable to interact with solvent due to an amino acid substitution or due to the lack 
of overexpression, the extrusion of organic solvents by this efflux system is too low 
to prevent their influx but sufficiently high to overcome the antibiotic influx. P. 
putida SI2 does not have to rely on ArpABC-mediated solvent efflux for its solvent-
tolerant phenotype, since it possesses the SrpABC efflux system that is induced 
under solvent stress. 
TRANSPOSON MUTATIONS IN THE FLAGELLA BIOSYNTHETIC PATHWAY 
OF THE SOLVENT-TOLERANT PSEUDOMONAS PUT/DA S 1 2 RESULT IN A 
DECREASED EXPRESSION OF SOLVENT EFFLUX GENES 
Jasper Kieboom, Riekje Bruinenberg, Ineke Keizer-Gunnink and Jan A. M. de Bont 
SUMMARY 
Fourteen solvent-sensitive transposon mutants were generated from the solvent-
tolerant Pseudomonas putida S12 by applying the Tn/Wod-KmO mutagenesis system. 
These mutants were unable to grow in the presence of octanol and toluene. By 
cloning the region flanking the transposon insertion point a partial sequence of the 
interrupted genes was determined. Comparison of the deduced amino acid 
sequences with a protein database revealed the following interrupted putative gene 
products: organic solvent efflux proteins SrpA and SrpB, the flagellar structural 
proteins FlgK, FlaG, FIN, FliC, and FliH, the transcriptional activator FleQ, the 
alternative RNA polymerase sigma factor RpoN, and the flagellum specific RNA 
polymerase sigma factor FN A (RpoF). The transposon mutants, except for the 
organic solvent efflux mutants, were nonmotile as determined by a swarm assay 
and the formation of the flagellum was totally impaired. Expression studies with a 
srp promoter probe showed a decreased expression of the SrpABC efflux pump in 
the nonmotile mutants. 
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INTRODUCTION 
In the last decade several solvent-tolerant Pseudomonas putida strains [15, 49, 110, 
116, 145] have been isolated that are able to grow in two-phase water organic 
solvent systems that are lethal for normal bacteria. Solvent-tolerant strains are able 
to counterbalance the toxic effects of organic solvents, at the level of the bacterial 
cell membrane, through a variety of mechanisms. The head group formation of the 
membrane phospholipids may be changed [144], the c/s-unsaturated fatty acid 
may be isomerized to the more rigid trans configuration [39], the phospholipids 
content or the basal rate of phospholipid biosynthesis may be increased [109, 
110]. At the level of the outer membrane, changes in the lipopolysaccharide (LPS) 
content [3], LPS composition [109], and cell hydrophobicity have been observed 
[144]. 
These modifications do not fully explain the high organic solvent tolerance levels of 
several P. putida strains. Therefore, it was anticipated that a dynamic efflux system 
for organic solvents had to play a role in solvent tolerance. Such a mechanism was 
indeed identified in P. putida S12 [55] and the genes (srpABC) for the active efflux of 
organic solvents were subsequently cloned and sequenced [64]. This energy-
dependent export system is involved in the resistance to a wide variety of organic 
solvents in P. putida S12. The SrpABC efflux system was induced by organic 
solvents [63] and not by other environmental stress factors. Recently, several efflux 
pumps have been described in other strains and underline the importance of 
organic solvent efflux in solvent tolerant pseudomonads [27, 67, 78, 117]. 
This study was carried out to identify alternative mechanisms involved in P. putida 
S12 solvent tolerance by isolating solvent-sensitive mutants. The solvent-sensitive 
mutants were physiologically characterized and the interrupted genes were partially 
sequenced. Moreover, we determined the effect of these transposon insertions on 
the expression of the organic solvent transporter SrpABC and discuss the 
relationship between the interrupted gene products and organic solvent efflux. 
MATERIALS AND METHODS 
Bacterial strain, plasmids and growth of strains 
P. putida S12 [33] is the wild-type organic solvent-tolerant strain capable of growth 
at saturated solvent concentrations [145]. The P. putida mutants were derived in 
the present work by transposon mutagenesis. E. coli DH5a [158] was utilized as the 
host strain for all recombinant plasmids. The transposon Tn/Wod-KmO [18] was 
used for the construction of P. putida S12 mutants. The promoter probe pKRZ-srp 
[63] and the cloning vector pJWBl [148] were used to construct the promoter 
probe pLFl. Luria-Bertani (LB) broth [126] was used as complete medium. Solid 
media contained 2% agar. Kanamycin (50 ng/ml) and gentamicin (10 ng/ml) was 
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added to the medium to select for Tn/Wod-KmO integrands and to maintain 
recombinant plasmids in E. coli. P. putida strains were routinely cultured at 30°C 
and E, coli strains were grown at 37°C. 
Transposon mutagenesis 
The transposon TnMod-KmO was introduced into P. putida S12 by electroporation 
[19] using a Gene Pulser (Bio-Rad). Kanamycin-resistant transposon mutants were 
tested for the ability to grow in the presence of 10% (v/v) octanol. This was 
accomplished by inoculating 200 u.1 LB broth in 96-wells microtitre plates 
supplemented with 10% (v/v) octanol and subsequently placing them in a sealed 
glass desicator. Growth of the cultures was determined after 12 h at 30°C. Mutants 
unable to grow in the presence of 10% (v/v) octanol were selected and designated 
01 through 014. 
Cloning and partial sequencing of chromosomal DNA 
Isolation of total genomic DNA from P. putida, plasmid DNA isolation from E. coli, 
restriction endonuclease analysis, ligations, and sequencing were preformed as 
described previously [64]. To elucidate the possible functions of the genes 
interrupted in the isolated mutants, we determined the nucleotide sequence 
flanking the transposon insertion using the primers 5'-TTCCCGTTGAATATGGC-3' 
and 5-ACGCTCAGTGGAACG-3'. Therefore, chromosomal DNA was isolated, 
digested with the restriction enzyme Pst\ or Sst\, ligated at room temperature and 
electroporated to E. coli DH5a. Plasmids from kanamycin-resistant colonies were 
isolated and sequenced. The obtained nucleotide sequence was translated and the 
amino acid sequences, which had been interrupted by Tn/Wod-KmO, were compared 
to known protein sequences in the PRF database using the GenomeNet BLAST 
server [1]. 
Physiological characterization of transposon mutants 
Solvent sensitivity of the P. putida strains was determined in LB/acetate medium. P. 
putida cells were grown in 10 ml LB medium containing 60 mM sodium acetate, 
until the cells reached the early exponential growth phase. The growing cells were 
10 times diluted with fresh LB/acetate medium. Organic solvents were added to 10 
ml inoculated media in a final concentration of 2% (v/v). Growth was determined 
overnight with mild agitation at 30°C. The experiments were conducted twice with 
duplicate samples each time. 
Motility and electron microscopy 
The swarming ability of the P. putida strains was tested using semisolid agar plates 
containing LB medium and 0.3% agar. Motility was scored overnight at 30°C. For 
light microscopy P. putida cells were grown in LB broth for 4 h at 30°C to mid-
exponential phase. For electron microscopy, motile and nonmotile P. putida strains 
were negatively stained using 0.5% uranyl acetate. A droplet of the culture was 
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applied on a formvar-coated grid. In ca. 20 s the fluid was removed and the grids 
were washed with a droplet of distilled water, air dried and examined in a Philips 
CM10 transmission electron microscope operating at 80 kV. 
Induction studies 
To determine the srp promoter activity in the kanamycin-resistant transposon 
mutants we constructed a gentamicin-resistant promoter probe. PCR reactions for 
amplifying a fragment (containing the promoter region of srp already fused to the 
promoterless lacZ gene) were preformed using the promoter probe pKRZ-srp as 
template [63]. PCR reactions were performed as described previously [63] using 
the primers 5'-CGGATCCTCGACGCTGCTCTGGCGATGA-3' and 5'-CGCGGCCGCTT-
ATTTTTGACACCAGACCAAC-3', which contained added restriction sites for BamH\ 
and Notl, respectively. This 3.3 kb PCR fragment was digested with BamHI and Not\ 
and ligated into pJWBl creating the promoter probe pLFl. 
To determine the induction of the srp promoter P. putida cells harboring the 
promoter probe pLFl were grown in LB broth at 30°C. 3 mM toluene was 
supplemented when the cells reached an optical density of 0.3 at 600 nm. At an 
optical density of 1.4 at 600 nm p-galactosidase activity was determined in 
triplicate using the method of Miller with chloroform and sodium dodecyl sulphate 
to permeabilize the cells [86]. 
RESULTS 
Isolation of octanol-sensitive transposon mutants 
Octanol-sensitive mutants of P. putida S12 were generated using TnMod-KmO, 
allowing the rapid cloning of the genomic region adjacent to the TnMod-KmO 
insertion point. From a screening of 4000 kanamycin-resistant colonies 14 octanol-
sensitive mutants, designated 01 through 014, were isolated. Southern 
hybridization of Psfl-digested genomic DNA of these mutants with a probe for the 
kanamycin resistance cassette in TnMod-KmO revealed single hybridization bands 
suggesting single transposon insertion (data not shown). 
Sequence homologies 
In all octanol-sensitive mutants the region adjacent to the transposon insertion was 
cloned and sequenced (Table 6.1). The deduced amino acid sequences from the 
inactivated genes of mutant 06, 08 and 014 revealed that the transposon was 
integrated in the energy-dependent efflux mechanism SrpABC. This operon is 
responsible for the active efflux of organic solvents and was shown to play a role in 
organic solvent tolerance in P. putida S12 [64]. 
The interrupted genes in mutant 0 1 , 02, 07, 09 and 012 showed homology with 
structural proteins of flagella. The deduced amino acid sequences showed high 
01 
02 
03 
04 
05 
06 
07 
08 
09 
010 
O i l 
012 
013 
014 
flgK 
flaG 
fleQ 
rpoN 
fliA 
srpA 
mi 
srpB 
fliC 
fleQ 
fleQ 
fliH 
-X 
srpB 
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78 
100 
24 
84 
97 
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96 
84 
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98 
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87 
100 
51 
89 
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54 
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sequence homology with structural proteins such as FlgK, the flagellar hook-
associated protein (HAP1) [43], FlaG and FliC flagellin [134, 153], FIN, a putative 
flagellum-specific ATPase subunit of a protein translocase for flagellum-specific 
export, and FliH, a flagellar assembly protein [143]. 
Inactivated Number of deduced 
Strain gene amino acids Identity Homology (%) Organism Reference 
S. typhimurium 43 
P. putida 153 
P. aeruginosa 8 
P. putida 52 
P. putida 24 
P. putida 64 
S. typhimurium 143 
P. putida 64 
P. aeruginosa 134 
P. aeruginosa 8 
P. aeruginosa 143 
S. typhimurium 8 
100 100 P. putida 64 
TABLE 6.1 . Sequence homology the TnMod-KmO inactivated genes in the solvent-sensitive P. putida 
strains. The PRF database accession numbers are as follows; FlgK, 1613338B; FlaG, 2106279B; FleQ, 
2320269A; RpoN, 1604231A; FliA, 2410250D; SrpA, 2408344A; FliC, 2301229A; Flil, 1713317B; 
FliH, 1713317A; and SrpB, 2408344B. $ No homology was found. 
The inactivated genes in mutant 03, 04, 05, 010 and O i l revealed three 
inactivated regulators. The deduced amino acid sequence revealed strong homology 
with the transcriptional activator FleQ [8]. The other regulators found were the RNA 
polymerase cr54 factor RpoN [52] and the flagellum specific RNA polymerase factor 
aF FliA (RpoF) [24]. The putative function of the inactivated gene in mutant 013 
could not be determined since its deduced amino acid and nucleotide sequences 
did not show any significant homology with protein or gene sequences in 
databases. 
P. putida strain 
Solvent S12 01 02 03 04 05 06 07 08 09 010 O i l 012 013 014 
Decane + + + + + + + + + + + + + + + 
Hexane + + + + + + - + - + + + + + 
Cyclohexane + + + + + + - + - + + + + + 
p-xylene + + + + + + - + - + + + + + 
Octanol + _ _ _ _ _ _ _ _ _ _ _ 
Toluene + _ _ _ _ _ _ _ _ _ _ _ 
Fluorobenzene - - - - - - - - - - - - - - -
Benzene _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
TABLE 6.2. Growth of P. putida strains on LB/acetate in the presence of various solvents. Different 
solvents (2% final concentration) were separately added to identical subcultures in LB medium with 
60 mM acetate during the early exponential growth phase. Growth of the culture was measured at 
various times after solvent addition with no continued growth indicating solvent sensitivity. A plus 
indicates growth with OD > 0.7, while a minus indicates no growth with OD < 0.1 after 24 h. 
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Physiological properties of the solvent-sensitive mutants 
General growth characteristics, susceptibility to organic solvents, and motility of all 
solvent-sensitive strains were investigated. The growth curves of the mutants in the 
absence of organic solvents were similar to the wild-type P. putida S12 strain (data 
not shown). This indicated that organic solvent sensitivity was not due to altered 
growth characteristics. The sensitivity to various organic solvents was determined 
by adding 2% (v/v) organic solvent to growing cells in the early exponential growth 
phase. Growth was determined by measuring the optical density after overnight 
incubations at 30°C. As indicated in Table 6.2 the transposon mutants were not 
able to grow in the presence of 2% octanol and neither in the presence of 2% 
toluene. In addition, mutant 06, 08, and 014 were sensitive to p-xylene, 
cyclohexane, and hexane, which is similar to the previously described phenotype of 
the srpB mutant P. putida JK1 [64]. 
FIGURE 6.1. Electron micrographs of representative cells of the (A) wild-type P. putida S12 and the (B) 
nonmotile mutant P. putida 03. Bars, 1 urn. 
As a result of homologies that were found with the proteins involved with bacterial 
flagella we determined whether the mutant strains were motile. The motility was 
tested by a swarm test using semisolid agar plates. Mutant 06, 08, and 014, which 
were lacking the energy-dependent export system for organic solvent, were motile. 
All other organic solvent-sensitive mutant strains were nonmotile, including the 
unidentified mutant 013 (data not shown). These results were confirmed with 
electron microscopy. While the P. putida S12 and mutant 06, 08, and 014 were 
extremely motile, as determined by phase contrast microscopy, the other mutants 
were nonmotile. The electron microscopy experiments showed that P. putida S12 
contains 4 to 6 polar flagella, whereas a similar examination of several mutants 
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failed to detect any flagella [Figure 6.1]. Thus, the lack of motility in the mutants 
was due to their inability to form flagella. 
Induction of the solvent efflux transporter SrpABC 
Because the solvent transporter SrpABC is the main determinant for solvent 
tolerance in P. putida S12 [64], efforts were made to determine the expression of 
the solvent transporter in the nonmotile solvent-sensitive mutants. We constructed 
the promoter probe pLFl to measure expression of the efflux pump. As shown in 
Figure 6.2 the srp promoter activity decreased in all nonmotile mutants when 3 mM 
toluene was used as inducer. From these results we can conclude that mutations in 
the flagella biosynthetic pathway in P. putida S12 result in decreased expression of 
the srpABC genes. 
S12 01 02 03 04 05 07 09 010 011 012 013 
Strain 
FIGURE 6.2. Induction of P. putida S12 srp promoter. P. putida strains containing the promoter probe 
pLFl were grown in LB broth. At an optical cell density of 1.4 at 600 nm, 3 mM toluene was added, p-
galactosidase activity in uninduced (white bars) and toluene-induced (gray bars) cells was determined 
in triplicate cultures at an optical density of 1.4 at 600 nm. 
DISCUSSION 
Here we report the isolation of solvent-sensitive mutants from P. putida S12 by 
transposon mutagenesis. Sequence analysis showed that three out of fourteen 
mutants were disrupted in the previously described efflux mechanism SrpABC for 
organic solvents [64]. Five mutants were interrupted in the structural proteins of 
the bacterial flagella, while the others were interrupted in the regulatory proteins 
RpoN, FliA (RpoF) and FleQ. As determined by a swarming assay these 11 mutants 
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were nonmotile and were totally impaired to form flagella (Fig. 6.1). These results 
are intriguing since the role of the flagella biosynthetic pathway in solvent tolerance 
is unexpected. Other researchers have recently isolated organic solvent-sensitive 
mutants. Eight solvent-sensitive mutants were isolated from the toluene-tolerant P. 
putida GM7 [67]. It appeared that, in addition to proton-dependent efflux of organic 
solvents, an ABC-transporter, and enzymes possibly involved in repair mechanisms 
of damaged membranes, were disrupted in these toluene-sensitive transposon 
mutants. Moreover, two toluene-sensitive mutants from P. putida IH-2000 were 
interrupted in cytochrome o, although the exact role of the cyo gene cluster in 
solvent tolerance has not been determined [40]. Surprisingly, toluene-sensitive 
mutants of P. putida DOT-TIE were isolated that were also interrupted in an operon 
for the flagella biosynthetic pathway [123]. 
In mutant 04 the RNA polymerase a54 factor RpoN was interrupted. In P. putida 
RpoN is required for the expression of a broad range of genes involved in the 
formation of pili, the utilization of nitrate, amino acids as nitrogen source, C4-
carboxylates as carbon source and the degradation of toluene [53, 71 , 138]. 
However, the srp promoter seems to be a54-independent for no RpoN consensus 
sequence could be found in the srp promoter [63]. Therefore, other regulatory 
pathways have to play a role in the downregulation of the srp locus in the nonmotile 
mutants. We speculate that the strictly regulated cascade of the flagella 
biosynthetic pathway play a role herein. 
In Salmonella typhimurium the flagella biosynthetic pathway is organized into a 
transcriptional hierarchy of classes [83]. Each later class of operons is only 
transcribed when previous classes are completely functional. The expression of 
class 3 operons is mediated by the fliA gene product. In the solvent-sensitive 
mutants the formation of flagella was totally impaired, as demonstrated by electron 
microscopy. Therefore, it seems that the expression of class 3 operons is not only 
blocked in the FliA transposon mutant 05, but also in the other mutants. This 
regulatory mechanism has been shown to be controlled by anti-cr factors, which 
bind to the to the flagella-specific a factor FliA (RpoF) [44]. From our results one 
could speculate that this regulatory mechanism also affects the expression of the 
srp operon, resulting in solvent-sensitivity. In this light it is interesting to note that 
FlhF, a protein of the flagella biosynthetic pathway in P. putida, was found to be 
involved in general stress response [106]. 
The regulatory mechanisms of the srp operon have not been clarified yet. In 
contrast to a repressor upstream the organic solvent transporter locus found in 
other solvent tolerant strains, two putative regulators were sequenced upstream 
srpA (SrpR and SrpS, GenBank Accession Number AF061937), although their role 
remains unclear [147]. It seems that with the isolation of the flagella biosynthetic 
insertion mutants and the unexpected downregulation of the srp locus in these 
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solvent-sensitive mutants, another level of transcriptional regulation has to be 
accounted for in unraveling the molecular basis of organic solvent efflux and its 
regulation. 
CONCLUDING REMARKS 
Organic solvents are generally extremely toxic to living microorganisms. 
Nevertheless, in the past decade several microorganisms have been isolated that 
are tolerant to organic solvents. One such exceptional organic solvent-tolerant 
bacterium is P. putida S12. Solvent tolerance and antibiotic resistance in this 
bacterium was the object of investigation reported in this thesis. The results 
presented in this thesis are discussed here along with recent progress in the field of 
solvent tolerance. Moreover, some concluding remarks are made in view of future 
investigations in solvent tolerance and the possible applications of these bacteria in 
biotechnological production processes. 
SOLVENT TOLERANCE MECHANISMS 
Organic solvents target the cell envelope of Gram-negative bacteria, in which they 
preferentially partition. The accumulation of solvents in the cell envelope and the 
concomitant destruction of membrane fluidity, resulting in a deterioration of 
membrane functions, is the main reason for toxicity of organic solvents [see 
Chapter 2]. However, organic solvent-tolerant bacteria, like P. putida S12, are able 
to induce a variety of defense mechanisms to withstand the toxic effects of organic 
solvents [see Chapter 2]. 
The initial response to organic solvents in a bacterium is a stress response related 
mechanism. Fast changes in the membrane allow the bacterium to survive the 
initial shock of organic solvents. For instance the cis into frans-isomerization of 
membrane fatty acids is such a fast response mechanism [35, 146]. These rapid 
changes alone are not sufficient to resist the long-term toxic effects of organic 
solvents. Therefore, longer-lasting mechanism have to be induced to overcome the 
toxic levels of organic solvents. These long-lasting mechanisms, mainly at the level 
of the cytoplasmic and outer-membrane, can be divided into two groups. Firstly, 
mechanisms that strengthen the bacterial membrane, such as changes in the 
phospholipid headgroups [109, 115, 144], changes in the degree of saturation of 
membrane lipids [110, 146], and the presence of membrane embedded proteins 
[119, 120]. Secondly, mechanisms that retard the rapid influx of organic solvents, 
such as changes in the content of lipopolysaccharides or its composition [3, 110]. 
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However, these mechanisms alone cannot explain the exceptional resistance of 
some solvent-tolerant strains. An equilibrium concentration will eventually be 
reached in the membrane that is lethal for the bacterium, despite the strengthened 
membrane and the decreased influx of organic solvents. Therefore, a long-lasting 
mechanism has to be present in solvent-tolerant strains that actively removes the 
deleterious organic solvents from the membrane. 
ACTIVE EFFLUX OF ORGANIC SOLVENTS 
In 1996 strong indications were obtained that organic solvent was actively removed 
from the membrane of the solvent-tolerant P. putida S12 [55]. These results were 
confirmed in 1997 in another solvent-tolerant P. putida strain [115]. These findings 
supported the notion that efflux of organic solvents may be a key mechanism in 
solvent tolerance. However, it should be noted that only the interplay between efflux 
and a number of mechanisms that strengthen the membrane and retard the influx 
of organic solvents would result in solvent tolerance. 
With the assumption that efflux is the key mechanism in solvent tolerance we 
anticipated that we were able to isolate solvent-sensitive transposon mutants of P. 
putida S12. Indeed, in early 1998 we were able to isolate a solvent-sensitive mutant 
of P. putida S12. As described in Chapter 3 we isolated the srpABC genes from this 
mutant that encoded for an efflux pump able to actively remove organic solvents 
from the membrane. With this report we demonstrated that organic solvent efflux 
was a key mechanism in solvent tolerance. Since this initial observation several 
other research groups isolated organic solvent efflux systems in solvent-tolerant 
strains. The Ttg efflux systems from P. putida DOT-TIE [89, 117, 121], and the 
MepABC efflux system from P. putida KT2442 [27] all confirmed that active removal 
of organic solvents was the key mechanism in solvent tolerance. Interestingly, the 
efflux mechanisms for organic solvent were consequently linked to efflux of multiple 
antibiotics. The SrpABC efflux mechanism could not be linked to multidrug 
resistance since the SrpB lacking mutant was still resistance to various antibiotics. 
Therefore, we anticipated a second efflux mechanism in P. putida S12. Indeed, we 
were able to isolate the multidrug transporter ArpABC [see Chapter 5]. Although 
almost identical to the solvent transporter MepABC from P. putida KT2442 [27], 
ArpABC was not contributing to solvent tolerant phenotype of P. putida S12. 
MULTIDRUG RESISTANCE VERSUS SOLVENT-TOLERANCE 
The efflux systems for organic solvents were all very homologous to efflux systems 
of the resistance/nodulation/cell division family (RND). RND-family transporters 
are involved in the transport of antibiotics, heavy metals, and oligosaccharides [95, 
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107]. Several interesting questions arise in view of the homology between solvent 
transporters and multidrug transporters. Is the SrpABC efflux system involved in 
antibiotic resistance? Is the antibiotic efflux system ArpABC involved in solvent 
tolerance? 
Is SrpABC involved in multidrug resistance? 
It had already been observed that solvent tolerance and antibiotic resistance were 
closely correlated in the solvent-tolerant P. putida S12. In 1997 it was 
demonstrated that solvent-adapted cells were more resistant to multiple 
antibiotics, but cells grown in the presence of antibiotics were not tolerant to 
organic solvents [58]. These results can be explained in at least three different 
ways. First, the increased antibiotic resistance can be the result of active efflux by 
the solvent transporter. Second, the solvents can be able to induce an antibiotic 
efflux system. Third, the increased antibiotic resistance can be the result of other 
mechanisms induced by organic solvents preventing the influx of the toxin. 
The solvent transporter SrpABC seems not to be involved in multiple antibiotic 
resistance despite its homology to multidrug transporters. It was observed that a 
solvent-sensitive mutant of P. putida S12, which was inactivated in the SrpABC 
efflux system, was as resistant as the wild-type to antibiotics such as tetracycline, 
chloramphenicol, and p-lactams. These results indicated that other mechanisms 
have to be involved in multidrug resistance in P. putida S12. Indeed, as described in 
Chapter 5 an efflux system (ArpABC) for antibiotics is present in P. putida S12. This 
efflux system is involved in the efflux of tetracycline, chloramphenicol, novobiocin, 
erythromycin, streptomycin, and p-lactams. However, organic solvents were not 
able to induce the arp locus. Moreover, we demonstrated that the ArpABC efflux 
system was not involved in solvent tolerance in P. putida S12. Therefore, the 
enhanced antibiotic resistance of solvent-adapted P. putida S12 had to be due to a 
decreased influx of these chemicals. Isken has recently demonstrated that the 
permeability of the cell envelope for several growth substrates decreased due to the 
presence of organic solvent [54]. This decreased permeability of the cell envelope 
due to organic solvents might be the main reason for the increased multidrug 
resistance of solvent-adapted P. putida S12. 
Are antibiotic efflux systems involved in solvent tolerance? 
The ArpABC efflux system for antibiotics in P. putida S12 is involved in multidrug 
resistance. However, despite its high homology to the solvent/antibiotic 
transporters TtgABC and MepABC, ArpABC was not involved in efflux of organic 
solvents [Chapter 5]. In the multidrug-resistant P. aeruginosa, 4 efflux pumps have 
been described that are involved antibiotic efflux: MexAB-OprM [112], MexCD-OprJ 
[113], MexEF-OprM [68] and AmrAB [151]. Surprisingly, the mex encoded 
multidrug efflux systems of this pathogen were able to transport organic solvent 
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[78]. It has not yet been determined if the AmrAB efflux system in P. aeruginosa is 
able to extrude organic solvent from the membrane. 
REGULATION AND INDUCTION OF EFFLUX 
In P. putida S12 the expression of the solvent transporter SrpABC is induced by 
aromatic and aliphatic solvents and alcohols, whereas general stress conditions 
such as pH, temperature, NaCI and the presence of organic acids do not induce srp 
transcription [Chapter 4]. Upstream the srpABC operon two putative regulators were 
found. The putative regulator SrpR was most homologous to AcrR, the operon 
repressor of the AcrAB in E. coli [82]. The putative regulator SrpS was homologous 
to IcIR, the glyoxylate bypass operon repressor in E. coli [137]. As demonstrated by 
Wery era/, interruption of srpS by ISSi2 upregulates expression of SrpABC [147]. In 
P. putida DOT-TIE a homologous transporter, TtgGHI, was found. The organic 
solvent substrate range of this transporter was similar to SrpABC but in contrast, 
TtgGHI was able to transport antibiotics [121]. TtgGHI was expressed from a single 
constitutive promoter in the absence of toluene, while cells exposed to toluene 
expressed TtgGHI from two promoters, a constitutive one and an inducible one 
[121]. 
The ArpABC efflux pump is identical to TtgABC and MepABC [see Chapter 5]. The 
TtgABC system is constitutively expressed and is involved in tolerance to toluene, 
styrene, m-xylene, ethylbenzene and propylbenzene [121, 117]. Like MepABC and 
ArpABC, TtgABC is involved in resistance towards tetracycline, chloramphenicol, 
and ampicillin. In contrast to its homologue in P. putida S12, TtgABC and MepABC 
are able to transport organic solvents. The regulator of the ttgABC operon, TtgR, is 
identical to MepR and ArpR and was recently shown to repress ttgABC transcription 
in the presence of toluene [25]. As described in Chapter 5, induction of the arp 
locus in P. putida S12 could not be assessed. 
TtgDEF efflux system in P. putida DOT-TIE was only involved in toluene and styrene 
tolerance [89, 121]. This efflux system was induced by organic solvents and the 
transcription start of the TtgDEF operon in P. putida DOT-TIE was determined [89]. 
Moreover, a regulatory protein belonging to the IcIR family of transcriptional 
regulators, TtgT, was shown to be involved in regulation of TtgDEF expression in P. 
putida DOT-TIE [25]. 
It goes without saying that more detailed experiments are needed to fully 
understand the complex regulation of RND-efflux systems in P. putida. As 
demonstrated in Figure 7.1 the complete picture of regulation of efflux in P. putida 
is not yet complete. Especially the pathways of solvent or antibiotics stress signals 
need to be determined. The downregulation of the SrpABC system due to insertions 
CONCLUDING REMARKS 67 
in the genes for flagella biosynthesis [see Chapter 6] and the finding that a global 
regulatory protein TtgX in P. putida DOT-TIE was involved in ttgDEF and ttgABC 
transcription [25], already indicated that a complex picture of regulation pathways 
will emerge in the future. 
Solvent Antibiotic 
arpR 
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I 
FIGURE 7.1. Overview of regulation of organic solvent and antibiotic transporters in solvent tolerant P. 
putida. A plus indicates positive control and a minus indicates negative control. 
SCREENING FOR ORGANIC SOLVENT TOLERANCE MECHANISMS 
The physiological approach 
Active efflux might not be the only longer-lasting response to organic solvents. 
Researchers until now only focussed on the screening for toluene-sensitive mutants 
using transposon mutagenesis. This approach implies that the knocked out gene(s) 
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have to be crucial for the survival of the wild-type strain in the presence of organic 
solvents. In my opinion additional efflux systems might be present in P. putida S12 
but the isolation of these systems, based on transposon mutagenesis and 
subsequent physiological characterization, could be hindered by the activity of 
efflux mechanisms. Therefore, already solvent-sensitive mutants should be used to 
screen for efflux systems. For instance the absence of SrpABC, which is a key 
mechanism in solvent tolerance, would allow the isolation of other mechanisms 
(non-efflux mechanisms) that are involved in strengthening the membrane or in 
retardation of organic solvent influx. 
An important factor in the isolation of solvent-sensitive mutants is the medium 
composition. The solvent-sensitive phenotype of the transposon mutant P. putida 
JK1 was shown to be strongly dependent on the medium used [see Table 7.2]. It 
was demonstrated that this strain became more sensitive to organic solvents due to 
the presence of high concentrations of sodium acetate. Conversely, such a high 
concentration of sodium acetate was thought to induce the organic solvent-tolerant 
phenotype of P. putida S12, allowing this strain to survive the sudden shock of 
organic solvent [145]. Moreover, the use of rich medium increased the solvent-
tolerant phenotype of P. putida JK1. This could be due to the presence of 
magnesium or calcium ions, which were thought to have a stabilizing effect on the 
cell membrane [51, 116, 144]. 
Medium composition 
Solvent 
Hexadecane 
Decane 
p-Cymene 
Propylbenzene 
Hexane 
Cyclohexane 
Ethyl benzene 
p-Xylene 
Octanol 
Toluene 
Dimethylphtalate 
Fluorobenzene 
Benzene 
MM 
60 mM acetate 
+ 
+ 
-
-
-
-
-
-
-
-
-
-
-
MM, 0 .01% YE 
60 mM acetate 
+ 
+ 
+ 
-
-
-
-
-
-
-
-
-
-
LB 
60 
+ 
+ 
+ 
+ 
-
-
-
-
-
-
-
-
-
mM acetate 
LB 
5 mM acetate 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
-
-
TABLE 7.1 . Growth of the solvent-sensitive P. putida JK1 on different media in the presence of various 
solvents. MM; mineral medium, LB; Luria-Bertani broth, YE; yeast extract. 
From the results presented in Table 7.1 one could too easily conclude that only p-
xylene and toluene are substrates for SrpABC. However, at the whole cell level 
medium composition determines the tolerant or sensitive phenotype. Substrate 
specificity can only be examined using radiolabeled organic solvents as described 
by Isken and de Bont in 1996 [55]. 
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In conclusion, selection of optimal medium composition and the appropriate 
organic solvent could prove the most important factor in finding other genes 
involved in solvent tolerance. As demonstrated in Chapter 6, regulatory genes have 
been found by isolating solvent-sensitive mutants using a rich medium and a less 
toxic organic solvent. 
THE GENOMICS APPROACH 
In the past decade microbiologist have moved from describing a single 
physiological phenomena to describing a whole genome. The completion of 
microbial genomes is continuing with 43 bacterial genomes completed and an 
additional 130 bacterial genome sequencing projects in progress worldwide 
(www.tigr.org). With the sequencing of bacterial genomes a new science called 
bioinformatics emerged. Bioinformatics is composed of many different, yet 
interrelated scientific fields such as functional genomics, proteomics, and 
transcriptomics. Genomic studies uncovered many genome variations in closely 
related bacteria and revealed basic principles involved in bacterial diversification, 
improving our knowledge of the evolution of bacteria. Proteomic studies deals with 
proteins separated by two-dimensional gel electrophoresis. Selected protein spots 
can be identified by peptide-mass fingerprinting using matrix-assisted laser 
desorption ionization-time of flight (MALDI-TOF) mass spectrometry. 
Transcriptomics or transcriptional profiling uses DNA arrays to identify the level 
specific mRNA species at the genomic scale. From these emerging scientific fields 
it is clear that genomes are an continuing source of information. 
To understand the tolerance mechanisms in Pseudomonadacea, bacterial genomes 
are an excellent source and future research in this field will definitely benefit from 
the exploitation of these genome sequences. To date genome sequencing projects 
have been started for 5 Pseudomonads [Table 7.2]. Of the 5 projects the genome of 
P. aeruginosa PA01 has been published [136], the genome of P. fluorescence PfO-1 
is being annotated, and the other genome sequencing projects are still in progress. 
Number of Open reading frames found 
Strain Nucleotides sequenced (in Kb) in sequenced genome 
P. aeruginosa PAO-1 6264 5565 
P. fluorescence PfO-1 6528 5800 
P. putida KT2240 1033 812 
P. syringae DC3000 455 503 
P. stutzeri 274 213 
TABLE 7.2. Genome sequencing projects of Pseudomonads. 
To demonstrate the use of genome sequences in discovering new genes we used 
the P. aeruginosa PAOl genome sequence as an example to look for RND-type 
transporters. As described in Chapter 2 four RND-type of efflux mechanism are 
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know in P. aeruginosa involved in multiple drug and organic solvent efflux. Using the 
SrpB amino acid sequence we were able to find an additional 8 RND-type of 
transporters based of amino acid identity. One of these efflux mechanisms was very 
similar to the heavy metal transporter CzcABC from Alcaligenes eutrophus [93]. 
Seven of the RND-type of efflux mechanisms had no known function. Even in the 
not yet finished genome of P. fluorescence PfO-1 we were able to find 10 proteins 
homologous to SrpABC [data not shown]. 
Transporter 
(type of protein and 
MFP 
SrpA 
MexA 
MexC 
AmrA 
MexE 
PA3523 
PA4206 
PA4374 
PA2528 
PA1435 
CzcB 
PA0156 
PA0157 
PA3677 
382 
383 
387 
396 
414 
353 
370 
376 
426 
385 
484 
383 
356 
367 
RND 
SrpB 
MexB 
MexD 
AmrB 
MexF 
PA3522 
PA4207 
PA4375 
PA2527 
PA2526 
PA1436 
CzcA 
PA0158 
PA3676 
size in amino acids) 
1049 
1046 
1043 
1045 
1062 
1053 
1029 
1018 
1043 
1036 
1036 
1051 
1015 
1025 
OMP 
SrpC 
OprM 
OprJ 
-
OprN 
PA3521 
PA4208 
-
PA2525 
-
CzcC 
-
-
470 
385 
387 
-
472 
491 
487 
-
498 
-
428 
-
-
Identity of RND 
protein 
i n % 
100.0 
64.4 
47.3 
46.7 
37.7 
35.5 
29.5 
28.0 
25.8 
25.9 
24.3 
21.1 
20.9 
19.9 
to SrpB 
Substrates transported 
organic solvents 
drugs, organic solvents 
drugs, organic solvents 
drugs 
drugs, organic solvents 
ND 
ND 
ND 
ND 
ND 
divalent metal cation 
ND 
ND 
TABLE 7.3. Comparison of SrpABC and transporter homologues found in the P. aeruginosa PAOl 
genome sequence. Abbreviations: MFP, membrane fusion protein; RND, inner membrane (transporter) 
protein; OMP, outer membrane protein; ND, not determined. 
SOLVENT TOLERANCE IN BIOTECHNOLOGY 
The application of organic solvent-tolerant bacteria in biotechnology is an area with 
considerable opportunities. The uncovering of solvent tolerance mechanisms and 
the continuing expansion of isolated solvent-tolerant strains will greatly enhance 
the number of applications of solvent tolerance in biotechnology. Several possible 
applications of these interesting solvent-tolerant strains will be discussed. 
Solvent-tolerant bacteria as cell factories 
Organic solvent-tolerant bacteria can be used as cell factories for whole cell 
biotransformations. Solvent-tolerant production strains allow the use of two-liquid 
solvent-water systems. These systems have been studied in order to cope in 
production process with the accumulation of products that are toxic to non-tolerant 
bacteria [125]. The enhancement of production has been demonstrated in the 
formation of various mono- and diepoxides [127, 154]. Interestingly, recombinant 
E. coli strains have been used in two-liquid solvent-water systems reaching product 
concentrations up to 10 g/l [157]. However, the range of solvents that these non-
tolerant microorganisms can withstand is limited in these systems. Therefore, the 
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application of a solvent-tolerant production strain introduces a new degree of 
freedom. It can tolerate organic solvents that are considerably more hydrophobic, 
therefore, increasing extraction efficiency of many important hydrophobic fine 
chemicals. This has recently been demonstrated for the production of the model 
substrate 3-methylcatechol in a genetically modified P. putida S12 strain using 
octanol as an extracting organic phase [45, 46, 149]. 
Solvent-stable enzymes 
A second application of solvent-tolerant bacteria is the use of these strains as the 
source for solvent-stable enzymes. It has been demonstrated that an organic 
solvent-tolerant strain produced solvent-stable proteases and lipases [97, 98]. 
With the increasing diversity of solvent-tolerant strains such as Pseudomonas, 
Flavobacterium, Rhodococcus, Alcaligenes and even Bacillus [see Table 2.1], the 
spectrum of solvent-stable enzymes is concomitantly increasing. 
Environmental biotechnology 
Another application of solvent-tolerant microorganisms might be in the field of 
environmental biotechnology. High emission peaks of organic solvents in wastegas 
and wastewater treatment facilities are monitored very closely to prevent the toxic 
effects of the pollutants. Solvent-tolerant bacteria are better equipped to withstand 
these toxic chemicals. Therefore, bioremediation processes may become more 
stable by applying solvent-tolerant bacteria. Solvent-tolerant bacteria are able to 
degrade a variety of pollutants such as toluene, xylene, styrene and polychlorinated 
biphenyls [33, 99, 116]. Moreover, it has been demonstrated that the catabolic 
potential of solvent-tolerant bacteria is flexible, also in the presence of high 
concentrations of organic solvents [84, 116]. 
Transfer of solvent tolerance genes 
Transfer of organic solvent tolerance genes to non-tolerant strains seems not to be 
an attractive application of solvent tolerance in biotechnology. As outlined in 
Chapter 2, the complexity of solvent tolerance limits the level of solvent tolerance 
by transfer of one single tolerance mechanism. This was demonstrated in Table 3.2 
by transferring the solvent efflux system SrpABC to a solvent-sensitive P. putida 
strain. This strain became more tolerant to toluene but we were not able to 
accomplish tolerance to an organic phase of toluene. 
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SUMMARY 
The aim of the research presented in this thesis was to study the molecular 
mechanisms of organic solvent tolerance in Pseudomonas putida S12. This 
bacterium is capable of growth at saturated solvent concentrations, which are lethal 
to normal bacteria. Organic solvent-tolerant bacteria have potential advantages in 
either the remediation of highly polluted waste streams or biocatalytic applications for 
the production of specialty chemicals. The use of these bacteria in biocatalysis would 
allow the introduction of an organic phase to dissolve water-insoluble substrates or to 
remove toxic products. 
As a first step in the identification of genes involved in solvent tolerance, toluene-
sensitive transposon mutants of P. putida SI2 were generated. As described in 
Chapter 3, we were able to isolate the genes involved in toluene efflux using the 
toluene-sensitive strain P. putida JK1. The deduced amino acid sequences encoded 
by the srpABC genes isolated were highly homologous to proteins involved in 
proton-dependent efflux. Transfer of the genes for the toluene efflux pump to a 
normally toluene-sensitive P. putida strain resulted in the acquisition of toluene 
tolerance. From these results we conclude that organic solvent efflux is the key 
factor in solvent tolerance. 
In Chapter 4 it was found that the induction of the membrane associated efflux 
system SrpABC of P. putida S12 is inducible. Using a reporter vector, containing the 
srp promoter, it was determined that aromatic and aliphatic solvents and alcohols 
were capable of inducing the transcription the srpABC genes. However, antibiotics, 
heavy metals and general stress conditions (pH, temperature, NaCI, and organic 
acids) did not induce srp transcription. From the results presented in Chapter 4 we 
conclude that SrpABC-mediated efflux of organic solvents is solely induced by 
solvent stress. 
The high levels of antibiotic resistance of P. putida S12 and the relationship between 
solvent tolerance and antibiotic resistance triggered us to study multidrug 
resistance in this strain. In analogy to the results presented in Chapter 3 the first 
step in the identification of genes involved in multidrug resistance was to generate 
transposon mutants of P. putida S12. In Chapter 5 we describe the isolation the arp 
genes involved in chloramphenicol efflux, using the isolated chloramphenicol-
sensitive P. putida strains CM1 and CM2. Moreover, the ArpABC efflux system was 
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involved in the resistance towards tetracycline, carbenicillin, streptomycin, 
erythromycin, and novobiocin. Surprisingly, the deduced amino acid sequences 
encoded by the isolated arpABC genes were highly homologous to proteins involved 
in proton-dependent efflux of organic solvents. By constructing an arp-srp double 
mutant it was concluded that arpABC was not involved in efflux of organic solvents. 
In Chapter 6 octanol-sensitive mutants of P. putida S12 were isolated, which were 
interrupted in genes for the flagella biosynthetic pathway. These mutants were 
nonmotile and the formation of the flagellum was totally impaired. The expression 
of the SrpABC efflux pump in the nonmotile mutants was decreased, possibly due 
to general regulatory mechanisms. 
Several genes involved in multidrug resistance and solvent tolerance in P. putida 
S12 have been isolated and characterized. It would now be interesting to 
investigate the complex regulation of these systems and to identify new genes using 
the mutants described in this thesis. 
SAMENVATTING 
Het doel van het onderzoek, zoals beschreven in dit proefschrift, was het 
bestuderen van de moleculaire mechanismen van tolerantie voor oplosmiddelen in 
Pseudomonas putida S12. Deze bacterie is in staat te groeien in de aanwezigheid 
van verzadigde concentrates oplosmiddel. Deze hoeveelheden oplosmiddel is voor 
'normale' bacterien dodelijk, maar oplosmiddel tolerante bacterien kunnen dit 
overleven. Een mogelijke toepassing van deze bacterien zou gezocht moeten 
worden in de reiniging van zwaar verontreinigde afvalstromen of in de 
biotechnologische productie van chemicalien. Het gebruik van deze organismen kan 
leiden tot stabielere systemen. Ook kan een organische fase ge'i'ntroduceerd worden 
waarmee onoplosbare substraten opgelost of toxische producten geextraheerd 
kunnen worden. 
De eerste stap in de identificatie van genen die bij oplosmiddel tolerantie betrokken 
zijn, was het maken van oplosmiddel gevoelige mutanten van P. putida S12. Door het 
isoleren van de tolueen gevoelige stam P. putida JK1 konden de genen voor het 
transport van deze verbinding gekarakteriseerd worden. Dit staat beschreven in 
Hoofdstuk 3. De afgeleide aminozuurvolgorde van het geTsoleerde srpABC operon was 
sterk overeenkomstig met eiwitten betrokken bij protonen afhankelijk transport. Het 
overbrengen van deze genen naar een tolueen gevoelige P. putida stam leidde tot 
tolerantie voor tolueen. Uit deze resultaten kan geconcludeerd worden dat het 
transport van organische oplosmiddelen een sleutelrol speelt in de tolerantie voor 
oplosmiddelen. 
In Hoofdstuk 4 is aangetoond dat het membraan-gebonden transport systeem 
SrpABC in P. putida induceerbaar is. Een studie naar de srp promotor toonde aan dat 
aromatisch en alifatische oplosmiddelen in staat zijn om transcriptie van srpABC te 
induceren. Echter, antibiotica, zware metalen en algemene stress condities (zoals pH, 
temperatuur, NaCI en organische zuren) induceerden srp transcriptie niet. Uit de in 
Hoofdstuk 4 beschreven resultaten kan geconcludeerd worden dat transport van 
organische oplosmiddelen door SrpABC uitsluitend geinduceerd wordt door 
oplosmiddelen. 
De hoge tolerantie voor antibiotica in P. putida S12 en de aangetoonde relatie 
tussen deze tolerantie en oplosmiddel-tolerantie gaf voldoende aanleiding om 
antibiotica-tolerantie in deze stam te onderzoeken. De eerste stap in de 
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identificatie van genen voor antibiotica-tolerantie was net maken van antibiotica 
gevoelige mutanten. Hiertoe is een methode analoog aan die uit Hoofdstuk 3 
gebruikt. Met behulp van de twee geisoleerde mutanten, P. putida CMl en CM2, 
konden we de arpABC genen voor chlooramphenicol-tolerantie isoleren. Dit is 
beschreven in Hoofdstuk 5. Naast chlooramphenicol-tolerantie blijkt het ArpABC 
efflux systeem betrokken te zijn bij tolerantie tegen tetracycline, carbeniciline, 
streptomycine, erythromycine en novobiocine. Het is opvallend dat de afgeleide 
aminozuurvolgorde van arpABC grote overeenkomst vertoont met eiwitten die 
betrokken zijn bij het protonen afhankelijk transport van organische oplosmiddelen. 
Ondanks deze homologie is met behulp van een arp-srp dubbel-mutant aangetoond 
dat ArpABC niet betrokken is bij transport van organische oplosmiddelen. 
De in Hoofdstuk 6 beschreven transposon-mutanten zijn gevoelig voor octanol en 
blijken gemuteerd te zijn in de genen voor de biosynthese van zweepstaarten. Deze 
mutanten zijn niet beweeglijk en ze zijn niet in staat zweepstaarten te vormen. De 
expressie van het SrpABC transport systeem bleek in de niet beweeglijke mutanten 
verlaagd te zijn. De conclusie van dit hoofdstuk is dat transposon-inserties in de 
genen voor de biosynthese-route van zweepstaarten tot een verminderde expressie 
van SrpABC leidt, waarschijnlijk door algemene regulatie-mechanismen. 
Zoals in dit proefschrift beschreven is, zijn uit P. putida S12 enkele genen geisoleerd 
en gekarakteriseerd, die een belangrijke basis vormen voor tolerantie voor 
oplosmiddelen en antibiotica in deze stam. Het onderzoeken van de complexe 
regulatie systemen in en het identificeren van nieuwe genen aan de hand van de 
beschreven mutanten zal een uitdaging zijn. 
NAWOORD 
Houten, 28 januari 2002 
Op een warme zomerdag in 1994 werd ik totaal onverwacht opgebeld door Jan de 
Bont met de vraag of ik interesse had in een promotiebaan bij de vakgroep 
Industriele Microbiologie. Ik was er op dat moment nog niet uit wat ik na mijn 
studie wilde doen. Het feit dat ik op stage was, net bloedheet was en mijn interesse 
op dat moment meer uitging naar een ijskoud biertje op een van de gezellige 
terrasjes in Ceske Budejovice, bemoeilijkte een rationele keuze dan ook ten zeerste. 
Terug in Nederland en na een goed gesprek met Jan werd ik enthousiast en ben ik 
nog voor het einde van mijn studie begonnen als Assistent in Opleiding. 
Het onderzoek naar de biologische productie van N-gesubstitueerde catecholen 
bracht niet wat we gehoopt hadden. Het was dan ook na twee jaar dat er besloten 
werd het over een andere boeg te gooien. Eind 1996 ging ik voor 6 maanden naar 
de Verenigde Staten om een oplosmiddeltolerante bacterie, Pseudomonas putida 
S12, nitrocatechol te laten produceren. Om de toegevoegde waarde van een 
oplosmiddeltolerante bacterie te demonstreren, wilden we de productie hiervan 
vergelijken met die van een oplosmiddel-gevoelige mutant. Niet de productie van 3-
nitrocatechol maar de isolatie van deze mutant betekende echter een onverwachte 
doorbraak in het onderzoek. 
Het resultaat van deze keuzes ligt nu voor u. Het proefschrift is af en de tijd is 
gekomen om enkele mensen te bedanken. Jan, allereerst wil ik jou bedanken voor je 
steun en de mogelijkheid die je me heb geboden om het onderzoek af te ronden. 
Jouw nimmer aflatende belangstelling en enthousiasme voor het onderzoek naar 
oplosmiddeltolerantie hebben mij erg geholpen bij de totstandkoming van dit 
proefschrift. Tevens wil ik iedereen bedanken die heeft bijgedragen aan mijn 
proefschrift en aan de goede werksfeer op IM. In het bijzonder wil ik mijn VMT 
labgenoten bedanken. Sjaak, Arie, Harald, Jan W., Jan V. en Hans, bedankt voor de 
gezellige werksfeer op het VMT lab en jullie betrokkenheid bij mijn onderzoek. Ik 
heb onze vakinhoudelijke discussies naast nuttig ook leuk gevonden. Vooral de 'gat' 
theorie was erg verhelderend. 
Furthermore, I would like to thank Gerben Zylstra and Jon Dennis for their 
contribution to my thesis. The discovery of the srp genes was a major breakthrough 
and was a new impulse in my research. Gerben, thank you for giving me the 
opportunity to work in your laboratory. I enjoyed it very much and I had a great 
time at Rutgers. Jon, thank you for teaching me the principles of prokaryotic 
genetics. Without your help my thesis wouldn't be the same. 
Tenslotte wil ik Wim en Sigrid bedanken voor hun steun en het feit dat zij mij de 
mogelijkheid hebben geboden om het tot hier te schoppen. Mascha, ik kan mij nog 
momenten genoeg bedenken dat ik niet te genieten was omdat een experiment 
mislukt was en ik weer met een sacherijnige kop voor de TV zat. Bedankt voor je 
steun en dat je er gewoon voor mij was. 
Momenteel raast er een zware storm door Nederland en de eerste zandzakken zijn 
op het NOS-journaal gesignaleerd. Storm en zandzakken, beter kan ik de weg naar 
de voltooiing van een proefschrift niet verwoorden. Gelukkig is het soms ook zomer. 
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